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 While exploring the differences in psychological and physiological fatigue among 
cancer survivors is not completely novel, the relationship between muscle function and 
perceptions of fatigue in cancer survivors remains mechanistically unclear. Furthermore, 
the effect of exercise on objectively measured muscular fatigue has yet to be studied in 
cancer patients. PURPOSE: To evaluate the relationship between subjective self-
reported psychological fatigue measures and objectively-measured muscular fatigue in 
cancer survivors following a 24-week exercise intervention. METHODS: Cancer 
survivors were asked to complete two measures of fatigue prior to and following 12 and 
24 weeks of an exercise intervention. Participants completed the revised Piper Fatigue 
Scale (PFS) which produces a total score (PFST) and four subscale scores. A handgrip 
fatigue index (HFI) was determined for each participant by repetitively squeezing a 
handgrip dynamometer maximally for 15 repetitions. Participants also completed 15 
maximal force knee extensions at a joint velocity of 60 deg∙s-1 and a quadriceps fatigue 
index (QFI) was computed. RESULTS: Significant positive relationships between the 
HFI and PFST (r = .303; p < .001), PFSB (r = .287; p < .001), PFSA (r = .220; p < .001), 
PFSS (r = .352; p < .001), and PFSC (r = .301; p < .001) were observed. In addition, peak 
hand force (PHF) was significantly negatively correlated to PFST (r = -.177; p = .027), 





intervention, significant main effects were found for PFST and all four subscales (p < 
.05). Results indicate significant decreases in PFST (p = .001), PFSB (p = .015), PFSA (p 
= .001), PFSS (p = .001), and PFSC (p = .004) following 12 weeks of the exercise 
intervention. Testing following 24 weeks of the intervention resulted in significant 
decreases in PFST (p = .031), PFSA (p = .023), and PFSS (p = .016). CONCLUSION: 
The lack of strong correlation between variables indicates self-reported fatigue measures 
may not be good predictors of fatigue at the muscular level and should therefore not be a 
primary determinant in exercise dose in cancer survivors. KEY WORDS: FATIGUE 
INDEX, MUSCULAR FATIGUE ASSESSMENT, REVISED PIPER FATIGUE 
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 An estimated 1.6 million new cases of cancer will have been diagnosed in the 
United States in 2015. This equates to more than 4,600 diagnoses each day (Siegel, 
Miller, & Jemal, 2015). Prostate, lung, and colorectal cancers are the most prevalent 
cancers among males, with prostate cancer accounting for one in five diagnoses. Breast, 
lung, and colorectal cancers are the most prevalent cancers among females, with breast 
cancer making up approximately one-third of all cancer diagnoses. It is estimated that 
nearly 600,000 Americans will die from cancer this year with the most common causes of 
death being from lung and bronchus cancer. The lifetime probability of being diagnosed 
with an invasive form of cancer is higher for males at approximately 42% than for 
females whose risk is slightly less at 38%. For adults under the age of 50, cancer risk is 
actually higher for females (5.4%) than for males (3.4%) due to the high amount of 
breast, thyroid, and genital cancers diagnosed in younger women (Siegel et al., 2015). 
 For many of the most prevalent cancers, overall incidence and mortality rates 
have been steadily declining since 1990. In addition, all-cause mortality rates have 
decreased by 23% since 1991. Despite the observed reductions in incidence and mortality 
rates, cancer is now the leading cause of death in nearly half of the states in the U.S. The 
number of people living following cancer diagnosis is expected to grow from 14.5 
million to 19 million by 2024 (Kohler et al., 2015). The 5-year relative survival rates for 






Americans over the past 30 years (Siegel et al., 2015). Increased survival rates may be 
attributable to current progressive methods of prevention, detection, education, improved 
treatment methods, and/or increased implementation of individualized cancer 
rehabilitation programs. These increased survival rates contribute to greater numbers of 
cancer survivors that may be living with the side effects of cancer treatments (Dittus et 
al., 2015). 
 Treating cancer is often challenging and involves techniques that may include 
surgery, radiation, chemotherapy, immunotherapy, hormone therapy, or various 
combinations of treatments. Type of treatment is dependent on a wide variety of factors 
including cancer type, stage, and location. Cancer treatments are generally known to 
negatively affect many dimensions of an individual’s life and have been associated with 
decreased endurance, decreased muscular strength, and increased fatigue. In addition, 
side effects may include decreased bone density, cardiotoxicities, cognitive defects, and 
pulmonary dysfunction (J. C. Brown, Winters‐Stone, Lee, & Schmitz, 2012). The 
majority of cancer patients experience one or more side effects or symptoms during and 
following treatment with the most common being pain, emotional distress, and fatigue. 
The management of side effects from cancer treatment is an important aspect of patient 
care, and can positively influence quality of life, as well as psychological and physical 
functioning (Siegel et al., 2012).  
 The most common symptom cancer survivors report is cancer-related fatigue 
(CRF). It is estimated that 60-96% of cancer survivors report CRF as a side effect of 
cancer treatment (Mock et al., 2000; Morrow, Andrews, Hickok, Roscoe, & Matteson, 






and exhaustion and has a considerable negative effect on quality of life (QOL) (Mock et 
al., 2000; Wagner & Cella, 2004). The impact of CRF on a patient’s functional capacity 
can be significant, and is therefore one of the most distressing of reported symptoms 
(Hofman, Ryan, Figueroa-Moseley, Jean-Pierre, & Morrow, 2007). Critical components 
of CRF are different from what is normally understood as fatigue. It is unrelieved by rest, 
and is not a result of activity. The aforementioned phenomena suggest that other 
mechanisms may be responsible for the observed differences in CRF versus exercise-
induced fatigue (Morrow et al., 2002). Additionally, CRF has been reported among wide 
ranges of cancer types, stages and treatment protocols. Therefore, CRF does not appear to 
be initiated by a specific cancer type or treatment, which suggests that unknown 
physiological mechanisms may be responsible for the physical manifestations observed 
among patients with CRF (Hofman et al., 2007).  
 The extent to which CRF is negatively affected by the cancer itself, cancer 
therapies, or a combination of factors is currently unclear (Saligan et al., 2015). Several 
mechanisms have been suggested to underlie the development of CRF; however, the 
pathophysiology is still largely misunderstood as both psychological and physiological 
factors appear to play a role (Ahlberg, Ekman, Gaston-Johansson, & Mock, 2003; Ryan 
et al., 2007; Saligan et al., 2015; X. S. Wang, 2008). Other factors such as tumor necrosis 
factor-α (TNF-α), physical inactivity, and weight loss may contribute to CRF by 
decreasing muscle mass, resulting in inhibited muscle contractile force, and impairing 
activities of daily living (Kasper & Sarna, 2000). In light of this, accurate assessment of 
CRF is often times a significant challenge for clinicians. Fatigue in healthy individuals is 






explaining the pathophysiology should account for both dimensions (Morrow et al., 
2002).  
There is currently no universally accepted standard for CRF measurement. Self-
report measures in the form of surveys are the most widely used and accepted forms of 
CRF assessment. However, these methods are only measuring one dimension in 
subjective fatigue (Ahlberg et al., 2003). Subjective fatigue is a complex construct but 
likely has links to reductions in physiological capacity (M. S. Miller, Callahan, & Toth, 
2014). Self-report measures are clearly missing a critical component, which is that the 
biological or physiological mechanisms might explain the physical manifestations of 
CRF. When assessing CRF, both subjective and objective data should be considered; 
however, at this time there is no validated objective CRF measurement (Ahlberg et al., 
2003). Therefore, accurate measures of both psychological and physiological fatigue are 
necessary to determine the most appropriate treatment methods for patients experiencing 
CRF. In addition, this will also allow researchers to evaluate the effectiveness of fatigue 
intervention strategies (P. C. Stone & Minton, 2008).    
Functional capacity is a broad term used to describe capacity of an individual to 
perform activities considering a person’s body function, environmental factors, personal 
factors, and/or health status (Arena et al., 2007). In addition to CRF, a common side 
effect of cancer and its treatment is loss of functional capacity. This reduction in capacity 
makes physical activity and normal activities of daily living increasingly demanding 
(Der-Torossian, Couch, Dittus, & Toth, 2013). Since fatigue seems to be associated with 






physical activity as a treatment option for CRF to improve functional capacity (van Weert 
et al., 2006).  
Physical activity can attenuate multiple side effects of treatment, potentially 
reverse functional losses that occurred during treatment, aid in the prevention of long-
term effects, reduce the rate of recurrence, and increase survival (J. C. Brown, Winters‐
Stone, et al., 2012; Siegel et al., 2012). Both aerobic and resistance exercise training have 
been reported to be beneficial in cancer survivors both during and after treatment and 
have been shown to reduce CRF (Adamsen et al., 2009; Arnold & Taylor, 2011; J. C. 
Brown et al., 2011; J. C. Brown, Huedo-Medina, et al., 2012; Dimeo, 2001; Haas, 2011; 
Keogh & MacLeod, 2012; Kuchinski, Reading, & Lash, 2009; Litterini & Jette, 2011; 
Puetz & Herring, 2012; M. E. Schmidt et al., 2012; Schneider, Hsieh, Sprod, Carter, & 
Hayward, 2007a, 2007b; van Waart et al., 2015; Velthuis, Agasi-Idenburg, 
Aufdemkampe, & Wittink, 2010; Wyrick & Davis, 2009), improve functional capacity 
(L. W. Jones et al., 2012; Macvicar, Winningham, & Nickel, 1989; Vardar Yagli et al., 
2015), and increase muscular strength (Courneya et al., 2007; Fong et al., 2012; A. L. 
Schwartz & Winters-Stone, 2009; Segal et al., 2003; R. L. Siegel, J. Ma, Z. Zou, & A. 
Jemal, 2014; Speck, Courneya, Masse, Duval, & Schmitz, 2010; van Waart et al., 2015; 
van Weert et al., 2006).  
Several studies have indicated that a commonly observed reduction in muscle 
mass among cancer survivors and decreased functional capacity may be due to cancer 
and its treatments (Christensen et al., 2014; Kilgour et al., 2010; Weber et al., 2009). 
While exploring the differences in psychological and physiological fatigue among cancer 






perceptions of fatigue in cancer survivors remains mechanistically unclear (Kilgour et al., 
2010). Furthermore, the effect of exercise on objectively measured muscular fatigue has 
yet to be studied in cancer patients.  
Statement of Purpose 
The purpose of this study was to evaluate the relationship between 
physiologically measured muscular fatigue and psychological fatigue in cancer survivors 
following a supervised combined aerobic and resistance exercise intervention.  
Research Hypotheses  
H1 It was hypothesized that muscular fatigue would have a positive linear 
relationship to subjective fatigue survey scores. 
 
 H1 was tested by examining Pearson correlations between upper and 
lower body fatigue indexes and total CRF scores as assessed though the 
revised Piper Fatigue Scale (PFS). Correlations between fatigue indexes 
and each of the four subscales of the PFS including sensory, affective, 
behavior, cognitive and mood were also made. Similarly, correlations 
were also examined between peak torque and total PFS as well as between 
peak torque and each of the PFS subscales.  
 
H2 It was hypothesized that following exercise training there would be a 
reduction in both psychological and physiological fatigue. 
 
 H2 was tested using a repeated measures multivariate analysis of variance 
(RMANOVA) examining differences between total PFS, PFS subscales, 
upper and lower body fatigue index, and peak torque following a 12 and 

















Significance of Study 
Direct assessment of fatigue provided further understanding into how cancer 
survivors experience fatigue beyond solely administering questionnaire-based 
assessments. The potential relationship between the two fatigue dimensions provided 
insight into methods for improving CRF in cancer rehabilitation programming and 
targeting fatigue. Evaluating how exercise modulates psychological and physiological 

























REVIEW OF LITERATURE 
Effects of Cancer and its Treatments on Skeletal  
Muscle Structure and Function 
Cancer and its side effects on skeletal muscle have been a topic of recent study. 
Overall, cancer and its treatments are known to cause skeletal muscle atrophy and 
weakness. Because of the prevalence of atrophy and impaired functioning in the cancer 
population, it is difficult to discern whether impairment is due to damage to contractility 
or loss of contractile components themselves (M. S. Miller et al., 2014). Skeletal muscle 
atrophy is a significant side effect of cancer that greatly depends on the tumor type and 
stage of cancer. Cachexia is the term used to describe muscle and fat loss that occurs due 
to various chronic disease states. Cachexia that occurs in conjunction with cancer and/or 
its treatment is termed cancer-related cachexia, and unlike muscle wasting due to 
starvation it, cannot be remedied by nutritional interventions (Fearon, Glass, & Guttridge, 
2012; Fearon et al., 2011; Skipworth, Stewart, Dejong, Preston, & Fearon, 2007). Despite 
the prevalence of cachexia in the cancer population, cancer patients without cachectic 
symptoms have also shown significant impairments in muscle function and strength 
(Christensen et al., 2014; Toth et al., 2013) 
Cancer 
 Typically, malignant solid tumors of the head and neck, gastrointestinal tract, 






are also associated with greater amounts of muscle loss which can affect prognosis, 
survival, and quality of life (Der-Torossian et al., 2013). Decreases in skeletal muscle 
mass have been shown to reduce contractile function, increase muscle weakness, and 
decrease aerobic capacity (Bogdanis, 2012). Because of the debilitating effects of cancer-
related cachexia and its relation to poor outcomes, interventions to combat muscle loss in 
cancer patients has become a priority for oncologists (Der-Torossian et al., 2013). 
 Mechanisms of skeletal muscle atrophy from cancer lie largely in the imbalance 
of protein synthesis and breakdown. In animal models, the magnitude of this imbalance 
depends largely on the tumor type and stage (Lorite, Cariuk, & Tisdale, 1997; K. Smith 
& Tisdale, 1993; Strelkov, Fields, & Baracos, 1989). Data retrieved from studies utilizing 
human cancer patients are limited, however, some point to similar protein 
synthesis/degradation mechanisms which lead to muscle atrophy (Gallagher et al., 2012; 
J. P. Williams et al., 2012). Evidence suggests that decreases in skeletal muscle protein 
synthesis may be related to increases in serum level of proteolysis-inducing factor (PIF) 
which is released from some cachexia-inducing tumors (Al-Majid & Waters, 2008). In a 
reported study by Wigmore, Barber, Ross, Tisdale, and Fearon (2000), patients with 
higher levels of PIF had significantly greater weight loss than those without PIF detected. 
Additional studies have shown PIF to induce significant loss of lean mass in tumor 
bearing mice (Eley, Russell, Baxter, Mukerji, & Tisdale, 2007; Lorite et al., 1997; Lorite 
et al., 2001; Lorite, Thompson, Drake, Carling, & Tisdale, 1998; H. J. Smith, Lorite, & 
Tisdale, 1999). Insulin may also play a role in cancer-induced muscle loss.  Insulin is an 
important anabolic hormone that promotes regulation of protein synthesis and balance. 






types and may contribute to impaired protein synthesis (Copeland, Leinster, Davis, & 
Hipkin, 1987; Lundholm, Holm, & Scherstén, 1978; Makino, Noguchi, Yoshikawa, & 
Nomura, 1998; Yoshikawa, Noguchi, Doi, Makino, & Nomura, 2001).  
 Investigations into skeletal muscle contractile dysfunction in human cancer 
patients have been minimal, due to the difficulty in discerning whether the contribution of 
dysfunction is due to loss of muscle mass or another mechanism. A study by Weber et al. 
(2009), investigated isometric and isokinetic quadriceps strength in cachectic cancer 
patients compared with apparently healthy controls. After controlling for muscle mass 
there were no significant differences observed in dynamic or static strength between the 
groups. In contrast, a study by Stephens et al. (2012) found lower torque production in 
both cachectic men and women compared to a control group after adjusting for cross-
sectional area. Similarly, Toth et al. (2013) found cancer patients produced 25% lower 
torque after controlling for muscle mass compared to control subjects. An association 
was also found in this study between muscular strength and 6-minute walk performance, 
suggesting that any link between skeletal muscle dysfunction and reduced functional 
ability in cancer patients may be independent of muscle mass (Toth et al., 2013).  
 In addition to whole muscle contractile dysfunction, investigations into cellular 
and molecular mechanisms suggest intrinsic skeletal muscle dysfunction at the level of 
the myofilament (Der-Torossian et al., 2013). A study by Weber et al. (2007) showed 
significant decreases in Type IIx muscle fibers in advanced cancer patients. A study by 
Toth et al. (2013) investigated single muscle fiber size and contractile function in 
cachectic versus non-cachectic cancer patients. Results from this study observed non-






patients compared to controls. In regards to contractile function, single fiber tension was 
significantly lower (14%) in Type IIa fibers in patients with cancer compared to controls, 
however, no difference was found in Type I fibers. Additionally, when cachectic and 
non-cachectic patients were compared, there was no significant difference in contractile 
function between the groups indicating that decreased tension was not a result of 
cachexia. In the same study, an increase in myosin attachment time was reported in 
cancer patients compared with controls; however, no difference was found again between 
cachectic and non-cachectic patients. This increase in attachment time decreases 
contractile velocity and as a result decreases power output. Lastly, a 50% decrease in 
mitochondrial fractional area was found in cancer patients compared to controls as a 
result in decreased size of mitochondria rather than number. Results from this study 
support evidence of an increase in skeletal muscle dysfunction in cancer patients 
independent of muscle mass (Toth et al., 2013).  
 Mechanisms of tumor-induced muscle dysfunction are still relatively unclear. The 
majority of evidence in animal and human models points to tumor-induced inflammation 
and activation of oxidative stress (Christensen et al., 2014; Sakuma & Yamaguchi, 2012). 
Pro-inflammatory cytokines TNF-α, Interleukin-6 (IL-6), Interleukin 1 beta (IL1-β), and 
Interferon gamma (INF-γ) are all derived from cancerous tumors and with chronic 
exposure result in systemic inflammation. These cytokines can activate NF-κβ in muscles 
which signals transcription of E3 ubiquitin ligases that result in myosin heavy chain 
specific protein degradation (Acharyya et al., 2004; Guttridge, Mayo, Madrid, Wang, & 
Baldwin Jr, 2000; Moldawer, Rogy, & Lowry, 1992; Saligan et al., 2015; Skipworth et 






models, elevated levels of pro-inflammatory cytokines have been associated with 
significant weight loss in tumor bearing mice (Cannon et al., 2007). Interestingly, studies 
blocking inflammatory cytokines showed attenuation of cachexia in tumor bearing 
animals (Costelli et al., 1993; Enomoto et al., 2004). Studies conducted using human 
cancer subjects have shown elevated levels of TNF-α and IL-6 among cachectic 
individuals with cancer (Dillon et al., 2007; Karayiannakis et al., 2001; Krzystek-
Korpacka et al., 2007). Evidence of activation of these pathways exists before onset of 
cancer treatment and before muscle wasting is detected. This indicates that these 
pathways are likely responsible for initiating the early phases of muscle degradation 
(Bossola et al., 2003; Zampieri et al., 2010).  
 In addition to inflammation, the tumor itself can be metabolically active and 
consume large amounts of glucose (Vaupel, Kallinowski, & Okunieff, 1989). Most 
tumors use glycolysis as their primary energy source and compete directly with other 
organs and tissues for energy. This increased use of anaerobic metabolism results in 
increased reliance on the Cori cycle and gluconeogenesis to increase the availability of 
glucose for the body from non-carbohydrate precursors, resulting in excessive protein 
degradation (Koppenol, Bounds, & Dang, 2011; Warburg, Wind, & Negelein, 1927). 
While the research is limited, a few investigations suggest cancer-induced skeletal muscle 
contractile dysfunction is independent of muscle atrophy (Christensen et al., 2014; Toth 
et al., 2013).  
Chemotherapy 
Few studies have examined the direct effects of cancer therapies on muscle 






as well as increased muscular fatigability. Chemotherapeutic treatment may indirectly 
lead to increased fatigue though cancer-related cachexia and muscular atrophy. Other 
factors such as inflammatory cytokines, reduced physical activity, and weight loss may 
contribute to decreased skeletal muscle contractile function (Al-Majid & Waters, 2008; 
Kasper & Sarna, 2000). Researchers who conducted performance assessments on cancer 
survivors undergoing chemotherapy have documented muscle weakness, reduced 
muscular strength, and reduced endurance (Gilliam & St. Clair, 2011; Kasper & Sarna, 
2000; Toth et al., 2013). Underlying mechanisms of skeletal muscle dysfunction may be 
due to increased reactive oxygen species (ROS) and chronic inflammation. In skeletal 
muscle, exposure to high amounts ROS and circulating cytokines are known to produce 
muscle weakness and accelerate CRF (Gilliam & St. Clair, 2011; Reid & Moylan, 2011).   
Anthracycline-based chemotherapy regimens have been shown to produce a wide 
range of negative side effects, but its most severe side effect is cardiotoxicity (Von Hoff 
et al., 1979; S. Zhang et al., 2012; Y.-W. Zhang, Shi, Li, & Wei, 2009). The dose-
dependent cardiotoxicities observed in studies using these types of chemotherapy drugs 
appear to be independent of the type of cancer treated (J. C. Brown, Winters‐Stone, et al., 
2012). More recent investigations, however have begun to uncover the effects of 
doxorubicin on skeletal muscle dysfunction (Gilliam & St. Clair, 2011; Hayward et al., 
2013; Hydock, Lien, Jensen, Schneider, & Hayward, 2011). Several studies conducted in 
animals have shown that doxorubicin exposure negatively affects contractile function in 
skeletal muscle and that this dysfunction is dose dependent as with cardiotoxicity 
(Falkenberg, Iaizzo, & McLoon, 2002; Gilliam, Moylan, Ferreira, & Reid, 2011; Gilliam 






Mechanisms by which atrophy and dysfunction occur are not entirely understood, 
however, Gilliam et al. (2012) proposed that atrophy and dysfunction occur similarly to 
the TNF-α activated pathway induced by tumor dysfunction. One proposed mechanism 
contributing to muscle weakness in chemotherapy patients includes disruption in control 
of redox signaling and a state of oxidative stress. Chemotherapy agents directly and 
indirectly produce a state of oxidative stress due to overproduction of reactive oxygen 
species. Chemotherapy drugs directly produce ROS by interacting with molecular oxygen 
and undergoing redox cycling. They may also indirectly contribute to increases in ROS 
by decreasing anti-oxidant levels and reducing the body’s ability to guard against 
elevated oxidants. Evidence supports that elevated reactive oxygen species can increase 
protein degradation and subsequently decreases contractile force (Gilliam et al., 2012; 
Gilliam & St. Clair, 2011). In addition to doxorubicin, other anthracycline 
chemotherapeutic agents have been shown to induce contractile dysfunction, such as 
cyclophosphamide (Friedman et al., 1990), bevacizumab (Poterucha, Burnette, & Jatoi, 
2012) melphalan (Bonifati et al., 2000), and epirubicin (Gilliam & St. Clair, 2011).  
Radiation 
 Radiation therapy is used as a treatment modality in approximately 50% of cancer 
patients. While advances in technology have minimized exposure to non-cancerous 
tissues, surrounding healthy tissues are often times exposed (J. C. Brown, Winters‐Stone, 
et al., 2012). CRF is a common side effect of radiation and is reported in up to 80% of 
cancer patients. The prevalence of radiation-induced fatigue and its effects on skeletal 
muscle structure and function are difficult to quantify since chemotherapy is frequently 






decreased functional capacity, decreased quality of life, and persist for months to years 
following radiation (Segal et al., 2003). While radiation-induced cardiovascular toxicities 
have been reduced with more precise radiation delivery, increasing evidence shows 
neuromuscular and skeletal muscular complications from radiotherapy. Radiation 
exposure to muscle tissues may result in pain, weakness, fatigue, and focal myopathies. 
Muscular damage may result in impaired blood flow and hypoxia. This condition may 
upregulate the aforementioned pro-inflammatory cytokines, which can lead to decreased 
muscular strength, increased atrophy, and decreased protein synthesis. Other clinical 
evidence suggests damage to nerves, tendons, ligaments, and bone structure from 
radiation treatment (J. C. Brown, Winters‐Stone, et al., 2012). The addition of 
chemotherapy to radiation treatment has also been shown to significantly increase 
fatigue, which may suggest an additive effect. Despite the prevalence of CRF in cancer 
patients following radiotherapy, little is known about its etiology (Jereczek-Fossa, 
Marsiglia, & Orecchia, 2002).   
Radiation therapy can affect skeletal muscle by physically disrupting its structural 
integrity. Investigations in animal models have shown muscle injury following radiation 
to result in cell death, increased protein breakdown, muscle atrophy, and fibrosis 
(Gillette, Mahler, Powers, Gillette, & Vujaskovic, 1995). An early study by Rubin and 
Casarett (1968), found muscle injury and atrophy in back and neck muscles of cancer 
patients following treatment. Late complications have been reported from radiotherapy 
and carry risk of injury to muscle and soft tissue (Gillette et al., 1995). Radiotherapy to 
the thoracic region of the body has been shown to induce pulmonary damage and reduce 






cardiovascular fitness (L. W. Jones, Eves, Haykowsky, Freedland, & Mackey, 2009). 
One important consideration is that progression of muscle injury may continue for as 
long as 10 years following treatment and short-term follow-up could underestimate the 
severity of radiation injury (Gillette et al., 1995).  
Surgery 
 Surgery is the most common form of cancer therapy and is often accompanied by 
other therapies. A number of symptoms and side effects can occur as a result of surgery 
(J. C. Brown, Winters‐Stone, et al., 2012). For these reasons, as with radiotherapy, it is 
difficult to discern modifications to muscular function from surgical treatment alone. 
Fatigue is often a symptom reported by cancer patients. Following surgery, CRF has been 
related to decreased muscle strength and cardiovascular fitness (Dimeo, Thomas, Raabe-
Menssen, Pröpper, & Mathias, 2004). Surgical treatments in patients with lung cancer 
frequently result in decreases in pulmonary capacity and oxygen uptake which can induce 
pulmonary and cardiac dysfunction, thereby reducing functional capacity. In other 
cancers, surgical treatment has been associated with adverse outcomes such as 
lymphedema, reduced range of motion, prolonged periods of inactivity and bedrest, 
deconditioning, pain, functional limitations, muscle atrophy, and fatigue (J. C. Brown, 
Winters‐Stone, et al., 2012; L. W. Jones et al., 2011).  
Fatigue Overview 
Definitions and Measurement of Fatigue 
Muscle fatigue is a common symptom during exercise and sport but is also 
observed in many disease states and health conditions (Bogdanis, 2012). In the literature, 






accepted definitions (C. A. Williams & Ratel, 2009). Bigland-Ritchie and Woods (1984) 
defined fatigue as an exercise-induced reduction in the ability of muscle to produce 
power or force, irrespective of task completion. In this definition, fatigue can be 
measured and can also be used with different exercise modalities or intensities 
(Vollestad, 1997). Additionally, Edwards (1981) defined fatigue as the inability to 
maintain a required or expected force or power output under maximal or submaximal 
sustained contraction conditions. When applying a fatigue definition to that of dynamic 
contractions, a ‘loss of power output’ may also be included in the definition (Vollestad, 
1997). Other common terms that tend to be used interchangeably with fatigue include 
weakness and exhaustion. It is important, however, to distinguish between weakness and 
fatigue as weakness is generally used to describe low amounts of force and is 
independent of exercise (Vollestad, 1997). Although these are commonly accepted 
definitions surrounding an exercise activity, fatigue commonly occurs in other settings 
and/or clinical conditions and is defined differently (C. A. Williams & Ratel, 2009).  
In clinical conditions, fatigue is generally understood as a more subjective state 
and is characterized by an individual’s perception of weakness, lack of energy, decreased 
capacity for physical or mental work, or becoming easily tired. Evidence points to at least 
two dimensions of fatigue, one of subjective nature and one of objective nature (P. C. 
Stone, Richards, & Hardy, 1998). While perceived fatigue is useful clinically, it is 
difficult to discriminate between perceived and physiological fatigue (Gilliam & St. 
Clair, 2011). As with the varying definitions of fatigue there is also a variation in 
measurement techniques. Muscular fatigue is generally objectively measured though 






(EMG) activity, and contractile function (C. A. Williams & Ratel, 2009), whereas the 
subjective dimension of fatigue cannot be directly measured but is assessed though self-
report instruments such as a survey (P. C. Stone et al., 1998).  
Physiological Causes of Fatigue during Activity 
Causes of muscular fatigue involve many processes and can be specific to the 
task, psychological state, training status, and environmental factors. Fatigue during 
exercise is often due to declines in ability of the active musculature which is referred to 
as peripheral fatigue. In general, fatigue in the musculature or peripheral fatigue is 
understood to be a consequence of depletion of energy bearing metabolites and 
accumulation of others which impair the contractile ability of the musculature (Baldwin, 
Brooks, Fahey, & White, 2005). Fatigue may also be central which is understood as a 
loss of voluntary activated muscle due to neural mechanisms surrounding the 
neuromuscular junction (Yavuzsen et al., 2009).  
Physiological mechanisms of fatigue involve both energy metabolism and 
metabolic factors within the muscle including decreased phosphocreatine levels in the 
muscle, muscle glycogen depletion, and blood glucose depletion. Depletion of energy 
yielding metabolites limit the amount available for activity. Accumulation of metabolites 
include accumulation of protons, lactate, inorganic phosphates, and calcium which 
directly interfere with contractile mechanisms of the muscle (Baldwin et al., 2005). 
Cancer-related fatigue theories indicate that these same physiological mechanisms may 
be ongoing in cancer patients independent of physical activity as a result of the cancer 








 Muscular force and strength may be related but can be differentiated from 
perceived fatigue (Kasper & Sarna, 2000). Different from the definitions of muscular 
fatigue, CRF has been defined by the National Comprehensive Cancer Network as a 
persistent, subjective feeling of tiredness related to cancer and cancer treatment that 
interferes with usual functioning (Mock et al., 2000). Characterizations of the symptom 
include feelings of weakness, tiredness, and lack of energy. Additionally, CRF it is 
different from muscular fatigue as it is not relieved by rest or sleep and is not related to 
physical exertion (Glaus, Crow, & Hammond, 1996). Current measurements of CRF are 
subjective in nature and are assessed in the form of a survey. There is a lack of consensus 
on the most appropriate CRF assessment tool with more than 20 instruments currently 
being used in various settings. Thus, a lack of consensus exists as to which instrument is 
most appropriate for this population. Because of this lack of consensus and variation of 
measurement, prevalence can vary widely dependent on the scale used. Additionally, 
these scales vary widely on the number of questions and dimensions of fatigue that are 
assessed (Minton & Stone, 2008). 
 In a recent review, Minton and Stone (2008) identified all current CRF scales and 
divided them into unidimensional and multidimensional. Unidimensional scales cover 
only physical aspects of fatigue whereas multidimensional scales cover between two and 
five different aspects of fatigue. The five unidimensional scales that were identified as 
having the highest quality included the following: European Organization for Research 
and Treatment of Cancer (EORTC) QLQ C30 (Aaronson et al., 1993), the Fatigue 






Assessment of Cancer Therapy Fatigue (FACT-F) (Yellen, Cella, Webster, Blendowski, 
& Kaplan, 1997), the Profile of Mood States (McNair, 1971), and the Brief Fatigue 
Inventory (BFI) (Mendoza et al., 1999). Benefits to unidimensional scales are that they 
are quick to administer, widely used, and have robust psychometric data to support their 
use. Disadvantages include that measurement is limited to a sensation of physical 
impairment and therefore only covers one dimension of a multidimensional symptom. 
The review identified nine quality multidimensional scales including the following: 
Fatigue Questionnaire (FQ) (Chalder et al., 1993), the Fatigue Symptom Inventory (FSI) 
(Hann et al., 1998), the Lee Fatigue Scale (K. A. Lee, Hicks, & Ninomurcia, 1991), the 
Multidimensional Assessment of Fatigue (MAF) (Belza, 1995), the Multidimensional 
Fatigue Inventory (MFI-20) (Smets, Garssen, Bonke, & Dehaes, 1995), the 
Multidimensional Fatigue Symptom Inventory short form (MFSI-30) (Stein, Martin, 
Hann, & Jacobsen, 1998), the Schwartz Cancer Fatigue Scale (A. L. Schwartz, 2003), the 
Wu Cancer Fatigue Scale (Wu & McSweeney, 2004), and the revised Piper Fatigue Scale 
(PFS) (Piper et al., 1998). Multidimensional scales are not used as widely as the 
unidimensional scales.  
While they offer an advantage by covering more dimensions, they are often 
lengthier to administer. Additionally, while the measurement of other dimensions is 
deemed important, their results are not currently used in clinical practice (Minton & 
Stone, 2008). Of these scales the FACT-F, BFI, and PFS are the best validated fatigue 








Objective Measurement of Muscular Fatigue  
Non-cancer. Reliable measurement of muscle fatigue is dependent on the 
measurement of force generating capacity of the muscle as obtained through maximal 
voluntary effort or electrical tetanic stimulation. Maximal voluntary isometric 
contractions (MVIC’s) are often used for fatigue assessment in humans and commonly 
tested with knee extension exercises as the leg can be kept in testing position. The 
biomechanics of testing other muscle groups and areas is more difficult and therefore the 
use of MVIC’s to assess other muscle groups is less clear. Certain limitations arise when 
assessing maximal voluntary contractions since force output is partly dependent on the 
motivation of the subject.  Therefore, it has been suggested that maximal voluntary 
contractions should instead be considered maximal evocable force (Vollestad, 1997). 
In addition to force generation capacity, the ability to generate power is another 
important measurement of fatigue. Concentric contractions are more demanding 
energetically than isometric contractions as dynamic movement requires faster rates of 
ATP regeneration (Woledge, Curtin, & Homsher, 1985). Assessment of maximal power 
output can be done through constant velocity cycle ergometers or an isokinetic 
dynamometer and will elicit measurement of torque and total work (Vollestad, 1997). An 
advantage to using dynamic movement and concentric contraction for fatigue assessment 
is that the movement patterns more accurately mimic exercise and normal activities of 
daily living than isometric contractions (Christie, Snook, & Kent-Braun, 2011). 
Maximal force or power can also be examined by electrical stimulation of alpha 
motor neurons innervating the muscle directly. This type of assessment measures tetanic 






Because different muscle fiber types have different twitch potentiation, interpretation 
using this technique can be difficult. The advantage of this method, however, is that it 
bypasses central drive and offers comparison of central fatigue to that of peripheral 
fatigue. In addition to tetanic force, twitch force has been used to study the loss of force 
generating capacity and is a measure of low frequency fatigue (Vollestad, 1997). A direct 
measurement of peripheral fatigue can be conducted by examining the differences in 
twitch force before and after a fatiguing exercise. If the twitch force is significantly less 
following the fatiguing exercise, results suggest a loss of force generating capacity and 
serious muscle fatigue. Other twitch properties such as a slowed rate of contraction and 
relaxation can also indicate fatigue (Kisiel-Sajewicz et al., 2012). Early investigations in 
fatigue by Edwards, Hill, Jones, and Merton (1977) showed a faster decline in twitch 
force compared to tetanic force. Recovery of twitch force took much longer than that of 
tetanic force. Stimulation of muscle or nerve with different frequencies may provide 
estimates of reduction in efficiency of the signal from the excitation action potential to 
binding of calcium to contractile proteins in fatigued muscle (Vollestad, 1997).  
Cancer. As mentioned earlier, many factors contribute to the symptom of fatigue 
including biological factors and psychosocial factors. Therefore, when assessing CRF in 
a clinical setting, both objective and subjective assessment should be used (Ahlberg et al., 
2003). Studies measuring objective fatigue, however, are minimal compared to the 
amount of literature citing the use of surveys to assess CRF. Considering that many 
factors can contribute to muscle fatigue, the lack of an objective measurement of CRF 






factors associated with CRF, decreased physical activity as often seen in cancer patients 
can also be a contributing factor to increased fatigability (Bogdanis, 2012).  
An exploratory pilot study by Kasper and Sarna (2000) demonstrated differences 
in physiological and behavioral assessment of fatigue dimensions; however, this study 
was only done in breast cancer patients who underwent chemotherapy, and the study only 
involved three patients. While this study mentioned the use of a fatigue index 
methodology, authors only discussed differences in mean isometric strength rather than 
skeletal muscle fatigue as a result of chemotherapy treatments (Kasper & Sarna, 2000).  
A study by Yavuzsen et al. (2009) investigated whether CRF was a result of 
peripheral or central fatigue and compared results to a control group. Results from this 
study found that patients with CRF had greater perceived fatigue and decreased isometric 
contraction time compared to controls. Results also indicated lower amounts of muscle 
fatigue in CRF patients compared to controls, as measured through relative twitch force, 
which the researchers deemed resultant of central fatigue (Yavuzsen et al., 2009). A 
similar study by Kisiel-Sajewicz et al. (2012) used EMG, mean power frequency, and 
twitch force data to evaluate physiological fatigue in cancer patients who experienced 
CRF. Results from this study suggest that patients experiencing CRF do not undergo as 
much muscle fatigue as healthy individuals even though they feel as if their muscles are 
more exhausted, which are similar to findings by Yavuzsen et al. (2009). In both studies, 
CRF patients had shorter isometric sustained contractions than healthy subjects due to 
earlier perceived physical exhaustion. Results of the study by Kisiel-Sajewicz et al. 
(2012) were similar to those of Yavuzsen et al. (2009) in that central nervous system 






limitation to the generalizability of both of the aforementioned studies is the use of 
isometric contractions rather than a dynamic assessment.  
In addition to muscle fatigue, there in an increased need to investigate whether 
there is an independent or dependent relationship between CRF, muscle strength, and 
muscle mass. A study by Kilgour et al. (2010) investigated whether or not CRF is related 
to specific objective measures of muscle mass and strength in patients with advanced 
cancer. Hand-grip strength was used to measure upper body strength and an isokinetic 
dynamometer was used to measure lower body strength. Results showed CRF to be 
significantly and negatively correlated with skeletal muscle mass and strength. When 
corrected for muscle quality, which is force relative to mass, the correlation was no 
longer significant. Furthermore, this correlation between CRF and strength was only seen 
in men and not in women (Kilgour et al. 2010). Results from these investigations indicate 
that CRF is not solely a subjective feeling and support the use and validation of objective 
measurements.   
Causes of Cancer Related Fatigue 
The pathophysiology and mechanisms of CRF remains unclear (X. S. Wang, 
2008). As previously mentioned, skeletal muscle structure and function is affected by 
both the cancer itself and its treatment modalities, and fatigue is understood also to be 
caused by both mechanisms. In addition to mechanisms underlying muscular fatigue, 
other theories exist regarding CRF that are independent of muscular function including 
the following: dysregulation of circadian rhythm, hypothalamic-pituitary-adrenal-axis, 
anemia, vagal-afferent activation, and ATP regeneration (Ryan et al., 2007; Saligan et al., 






treatment and the disease including pain, depression, anxiety, cachexia, as well as other 
psychological and physical conditions. Despite these investigations there is still little 
understanding into reliable physiological markers as objective fatigue measures (X. S. 
Wang, 2008). 
Sleep disturbance is commonly reported in cancer patients and may result in an 
altered circadian rhythm. Clinical observations have investigated cortisol release and 
flattened circadian rhythms to be associated with an increase in fatigue (Ryan et al., 
2007). Bower et al. (2005) investigated cortisol secretion in breast cancer survivors and 
found that patients with fatigue had a significantly flatter cortisol release and a slower 
decline in cortisol throughout the day than those without fatigue. Several studies 
investigated activity levels, sleep disturbance and fatigue and found an inverse 
relationship between fatigue and activity levels and a positive relationship between 
fatigue and sleeplessness in cancer patients (Berger, 1997; Mormont et al., 1998; 
Mormont & Waterhouse, 2002). 
Cancer and its treatment may lead to a decrease in ATP regeneration and 
accumulation of metabolic byproducts in skeletal muscle affecting contractile ability 
(Andrews, Morrow, Hickok, Roscoe, & Stone, 2004). Studies in patients with chronic 
fatigue syndrome have shown reduced oxidative metabolism (Lane, Barrett, Taylor, 
Kemp, & Lodi, 1998) and reduced skeletal muscle concentrations of ATP (Pastoris et al., 
1997), however, evidence in the cancer population is limited. One study reported reduced 
ATP levels in skeletal muscle of patients with cancer in addition to altered protein muscle 
metabolism (Collins, Bing, McCulloch, & Williams, 2002; Giordano et al., 2003). 






nutritional intake leading to decreased ATP regeneration (Ryan et al., 2007). A study 
investigating ATP infusions in lung cancer patients found improved muscular strength 
and quality of life indicating that perhaps this method could be used as a therapeutic 
modality (Agteresch, Dagnelie, van der Gaast, Stijnen, & Wilson, 2000).   
Effect of Exercise on Cancer-Related Fatigue 
Aerobic Exercise 
A number of exercise interventions in cancer patients have used a combination of 
both aerobic and resistance training. To investigate effects of each type of activity, they 
will be discussed separately. There is a large body of literature on aerobic exercise and its 
effects on CRF; however, there remains substantial variability in the outcomes. A recent 
review by Tian, Lu, Lin, and Hu (2016) included 26 studies that examined the effects of 
aerobic exercise on CRF and combined the results. Overall, aerobic exercise had a small 
but statistically significant positive effect which suggests that aerobic exercise could be 
beneficial in reducing CRF. Specifically, aerobic exercise was found effective in patients 
with nasopharyngeal carcinoma but overall was not found significant for breast cancer, 
prostate cancer, or colorectal cancer. Limitations to a study like this include different 
measurements of fatigue in addition to different modes, duration, and intensity of 
exercise. In this meta-analysis the most widely used fatigue scale was the FACT-F which 
interestingly found no significant effects on CRF with aerobic exercise.  
Studies using the BFI or PFS did, however, find significant effects of exercise on 
CRF (Tian et al., 2016). Therefore, the results of a non-significant effect of aerobic 
exercise should be cautioned as this study and others have shown that the FACT-F is not 






Aydiner, 2004; Tian et al., 2016). Additionally, the results of this meta-analysis are not 
consistent with the findings of other reviews which have shown significant positive 
effects of aerobic exercise in breast cancer patients (Cramp & Byron-Daniel, 2012; 
McMillan & Newhouse, 2011; Velthuis et al., 2010; Zou, Yang, He, Sun, & Xu, 2014). 
Evidence of the effects of exercise on CRF remains unclear in cancers of the prostate, 
colon, and blood (J. C. Brown, Huedo-Medina, et al., 2012; Cramer, Lauche, Klose, 
Dobos, & Langhorst, 2014; Velthuis et al., 2010). A meta-analysis by Velthuis et al. 
(2010) showed that supervised exercise programs were more effective in reducing CRF 
than home-based exercise programs in breast cancer patients. Interestingly, the type of 
exercise did not influence the beneficial effects on CRF indicating that the type of 
exercise can be tailored to the individual (Tian et al., 2016).  
Resistance Training 
Compared to the research on aerobic training alone and CRF, there are fewer 
studies that include only resistance training with CRF as an outcome. As mentioned 
previously, resistance exercise is known to improve muscular function in cancer 
survivors. A recent study by M. E. Schmidt et al. (2015) investigated the effects of a 12 
week resistance exercise program on fatigue in breast cancer patients undergoing 
chemotherapy. The Fatigue Assessment Questionnaire (FAQ) was used as a 
multidimensional assessment of fatigue. Results from this study showed a decrease in 
fatigue, however, not significant. A study by Courneya et al. (2007) found similar results 
when comparing aerobic to resistance exercise in breast cancer patients currently 
undergoing chemotherapy. Patients were randomized to a usual care, aerobic, or 






There no significant difference was observed between the aerobic or resistance group 
indicating that neither training modality was more effective at reducing in CRF. A similar 
study by Segal et al. (2009) compared aerobic to resistance exercise in men undergoing 
radiotherapy for prostate cancer. Participants in this study were also randomized to a 
usual care, aerobic, or resistance exercise intervention. In contrast to the study by 
Courneya et al. 2007, results from Segal et al. (2009) showed both the aerobic and 
resistance intervention significantly improved CRF, however, no significant differences 
were found between exercise groups. These studies are also consistent with the meta-
analysis by Velthuis et al. (2010) which showed a small but non-significant reduction in 
CRF with resistance exercise in both prostate and breast cancer patients. 
In contrast, a meta-analysis by J. C. Brown, Huedo-Medina, et al. (2012) 
examined the effect of exercise interventions on CRF and found that the greatest 
reductions in CRF occurred in patients who participated in moderate intensity or higher 
resistance exercise. Interventions using low intensity resistance exercise showed no 
significant reduction in CRF (J. C. Brown, Huedo-Medina, et al., 2012). Additionally, 
two recent studies found significant reduction in fatigue among breast cancer patients 
after they participated in a resistance training program (Hagstrom et al., 2016; Steindorf 
et al., 2014). While current exercise guidelines for cancer survivors recommend 
complimenting resistance exercise with aerobic exercise (Schmitz et al., 2010) other 
organizations like the American Cancer Society make little mention of including 
resistance exercise (Doyle et al., 2006). Mechanisms for the effectiveness of resistance 
exercise are likely due to the attenuation of muscle wasting, increased protein synthesis, 






Considering the evidence of the effects of aerobic and resistance exercise, as 
recommended by the American College of Sports Medicine (ACSM) guidelines, a 
rehabilitation program that includes a combination of aerobic and resistance exercise 
seems most efficacious to have the greatest effect on reducing CRF.  
Physical Activity and its Effects on Skeletal  
Muscle Structure and Function 
Repeated bouts of muscle contraction are an intense stimulus for physiological 
adaptation. Over time and with frequent exercise training sessions, skeletal muscle 
demonstrates a wide variety of functional adaptations in response to repeated muscle 
contractions. Training induced adaptations include changes in contractile apparatus, 
contractile proteins, metabolic adaptations, changes to intracellular signaling, 
transcription and translation, and modifications to mitochondrial size, density, and 
function. At the whole body level, training induces changes to size, strength, and power 
output of skeletal muscle in addition to modifications of fiber types. In general, the term 
exercise encompasses a variety of muscle contraction types and includes several 
modifiable variables including frequency, intensity, modality, and duration. Additionally, 
the exercise may refer to both aerobic and resistance types of activities. Aerobic exercise 
generally consists of high frequency, low power output contractions whereas resistance 
training generally consists of low frequency, high power output contractions. Therefore, 
adaptations and molecular responses are different, dependent on the type of activity in 
addition to frequency, intensity, modality and duration (Egan & Zierath, 2013).  
Adult human skeletal muscle is generally composed of equal proportions of slow 






and are more fatigue resistant than fast fibers. Fast twitch fibers can be divided into two 
subtypes of Type IIa and Type IIx where Type IIa have a greater oxidative capacity and 
are more fatigue resistant than Type IIx fibers, but more fatigable and have less oxidative 
capacity than Type I fibers. Training can induce adaptations to fiber types in addition to 
motor unit types; however it has not been shown to produce any major shifts in 
distribution of slow and fast fibers in skeletal muscle (B. Saltin & Gollnick, 1983).  
Aerobic Exercise 
 In general, known alterations of skeletal muscle in response to endurance training 
are increases in Type I fiber type area (Costill, 1972; Gollnick et al., 1973; Häkkinen & 
Keskinen, 1989; Patton, Kraemer, Knuttgen, & Harman, 1990; B Saltin et al., 1976), 
decreases in Type II fiber type area (Howald, Hoppeler, Claassen, Mathieu, & Straub, 
1985), increases in mitochondrial number and size (Holloszy, 1967; B. Saltin & Gollnick, 
1983), and increases in capillary density (Hermansen & Wachtlova, 1971; B. Saltin & 
Gollnick, 1983). A majority of these adaptations are regulated by the alterations of 
muscle specific enzymes that regulate energy metabolism and therefore have a larger 
impact on muscular function than structure (Taylor & Bachman, 1999). The importance 
of these adaptations is seen as improved ability to produce ATP via oxidative 
phosphorylation, decreased lactic acid production at a given intensity, increased use of fat 
for energy allowing for sparing of carbohydrate, and improved efficiency in extracting 
oxygen from the blood. Increased oxidative capacity improves overall muscle 
metabolism and has been shown to improve insulin sensitivity (Bogdanis, 2012).  
 The benefits of aerobic exercise on cardiovascular fitness and health in 






2011; Haskell et al., 2007). The influence of aerobic training on skeletal muscle mass and 
function is less clear as some investigations have found no influence (Jubrias, Esselman, 
Price, Cress, & Conley, 2001; Short, Vittone, Bigelow, Proctor, & Nair, 2004; Sipila & 
Suominen, 1995; Verney, Kadi, Saafi, Piehl-Aulin, & Denis, 2006) and others citing 
significant muscular hypertrophy (Harber et al., 2009; Konopka et al., 2010; Lovell, 
Cuneo, & Gass, 2010; R. S. Schwartz et al., 1991). It was unclear if adaptations were 
specific to age or sex, which is a limitation in these studies. A study by Harber et al. 
(2012) examined the influence of aerobic training on whole muscle size and contractile 
function in both younger and older men. Results found improved aerobic capacity in both 
age groups, significantly increased whole muscle hypertrophy independent of age, and 
improved peak power of both slow and fast fibers. These results support earlier findings 
that aerobic exercise training can improve Type IIa contractile function and aerobic 
training can combat loss of muscle mass and function due to aging. Longer duration 
training studies have also shown that aerobic exercise increases muscle protein synthesis 
and supports evidence that aerobic training has the potential to increase muscular mass 
and strength (Harber et al., 2010; B. F. Miller et al., 2005).  
Resistance Training 
 Overall, aerobic exercise results in little or no gain in muscle mass and strength 
whereas major neuromuscular adaptations result from resistance training. As with aerobic 
adaptations, the extent of adaptation relies largely on the pre-training state of the 
individual along with the type, intensity, volume, task, and duration of training. Although 
the literature on resistance training is extensive, a general understanding exists regarding 






& Earle, 2008). The first 6-8 weeks of training result in increases in strength with much 
smaller if any increase in muscle size or cross-sectional area. This suggests that the early 
increases in strength are due to neural adaptations (Staron et al., 1994). These increases in 
neural function are largely a result of increased motor unit recruitment and firing rate (D. 
A. Jones, Rutherford, & Parker, 1989). A study by Adams, Harris, Woodard, and Dudley 
(1993) showed only 70% of muscle was activated during maximal effort in untrained 
subjects indicating potential for increased recruitment. Training has shown to increase the 
amount of muscle activated demonstrating an increased potential to recruit larger and 
more fast twitch motor units (Pensini, Martin, & Maffiuletti, 2002). 
 As the duration of training increases, hypertrophy of muscle fibers plays a larger 
role in increasing strength than neural adaptations. Hypertrophy refers to enlargement of 
skeletal muscle and occurs due to increased protein synthesis which increases contractile 
proteins allowing for increases in the size of myofibrils (MacDougall et al., 1995; 
MacDougall, Sale, Elder, & Sutton, 1976). Resistance training also increases the amount 
of glycolytic enzymes and thus cytosolic area further increasing muscle size 
(MacDougall, Ward, Sale, & Sutton, 1977). Additional adaptations include a decrease in 
mitochondrial density that does not result in a decrease in number of mitochondria 
(Baechle & Earle, 2008). A study by MacDougall et al. (1978) found a 26% reduction in 
mitochondrial density as well as a 25% reduction in mitochondrial volume to 
mitochondrial fiber ratio. These changes were also accompanied by significant increases 
in both fast and slow fiber type area. Conclusions indicated that the mitochondrial density 






 Additional adaptations to resistance training include fiber type transitions that 
contribute to increased muscular strength and power. Both Type I and Type II fibers are 
recruited during resistance training and in general cross sectional area of both fiber types 
is increased following training, however, not equally (Baechle & Earle, 2008). Following 
resistance training, there has been shown a greater increase in Type II fibers than Type I 
fibers (Hather, Tesch, Buchanan, & Dudley, 1991). Evidence of complete shifts in fiber 
type from training remains equivocal. Current evidence supports fiber type shifts from IIx 
to IIa following resistance training or to a more hybrid or intermediate type of fiber rather 
than a complete shift in true fiber type from II to I (Campos et al., 2002; N. Wang, 
Hikida, Staron, & Simoneau, 1993).   
Cancer Survivors 
 Cancer and its treatments, as mentioned, result in decreased aerobic capacity, 
decreased strength and flexibility, muscle atrophy, fatigue, depression, and an overall 
decrease in quality of life (Burnham & Wilcox, 2002). Exercise has been shown to have 
beneficial physiological effects and it can be considered as a therapeutic intervention for 
cancer survivors (Wolin, Schwartz, Matthews, Courneya, & Schmitz, 2012). Specifically, 
exercise has the capacity to directly modify skeletal muscle and potentially reverse 
dysfunction. The repeated muscular contractions that take place during both aerobic and 
resistance exercise stimulate physiological adaptations such as increased protein 
synthesis, muscular hypertrophy, changes in contractile and mitochondrial function, 
metabolic changes, and modifications to signaling pathways (Christensen et al., 2014). 
Therefore, physical activity could be of particular importance to advanced stage and 






(Stene et al., 2013). In 2009, the American College of Sports Medicine established 
exercise guidelines for cancer survivors based on a large body of evidence. These 
guidelines suggest that exercise is safe for survivors and could assist in reduction of side 
effects and morbidities from cancer and its treatment. Current guidelines are consistent 
with the 2008 Physical Activity Guidelines for Americans recommending 150 minutes of 
moderate intensity aerobic activity or 75 minutes of vigorous activity in addition to at 
least two days of resistance training per week (Committee, 2008). The American College 
of Sports Medicine guidelines also note that there may be other considerations with 
cancer survivors that would alter these recommendations based on the survivors’ 
condition. Additionally, exercise programs should be adapted for the individual based on 
health status, cancer treatment type, and disease trajectory (Schmitz et al., 2010).    
Investigations into physical activity in cancer survivors suggest that the majority 
of side effects from cancer and treatments appear to be ameliorated by exercise. Several 
review studies show strong evidence that exercise is an effective tool for rehabilitation 
after cancer (Burnham & Wilcox, 2002; Courneya, 2003; Fong et al., 2012; Speck et al., 
2010; Stevinson, Lawlor, & Fox, 2004). The majority of evidence, however, examining 
exercise and physical functioning in cancer patients has only evaluated the effects of 
aerobic exercise (Al-Majid & Waters, 2008). A review by Courneya (2003) evaluated 
exercise in cancer survivors. At the time of the review, the author found 28 studies of 
exercise in breast cancer patients and 19 in other cancers. Of these 47 studies, only three 
included resistance training interventions and of these three, two reported increases in 
muscular strength. The majority of studies in this review focused on outcomes of aerobic 






Stevinson et al. (2004) evaluated 33 controlled exercise trials and concluded that exercise 
improves physical function; however, there was no discussion on improvements to 
skeletal muscle function. More recently, Fong et al. (2012) evaluated physical activity in 
cancer survivors where only seven studies reported outcomes of physical functioning 
related to strength with no investigations into specific muscle function or muscle fatigue. 
While endurance exercise has a wide range of benefits, it has not been shown to increase 
muscle mass or muscle strength. Despite the evidence that muscle wasting and 
dysfunction contribute largely to CRF and a number of studies examining muscular 
strength in cancer survivors, few have examined the role of exercise in cachectic patients 
(J. C. Brown, Winters‐Stone, et al., 2012).  
As previously mentioned, resistance and aerobic exercise modulate changes in 
muscle function differently. A growing body of evidence is supported by controlled trials 
that have shown resistance training improves muscular strength in oncology patients, 
however, evidence on increased muscle mass is mixed. A study by Segal et al. (2009) 
evaluated the effects of a 24 week resistance training program in prostate cancer patients. 
Results showed a 22% increase in upper body strength and a 24% increase in lower body 
strength. Similar results were seen in a study done with breast cancer patients by 
Courneya et al. (2007), where a 25-35% improvement in muscular strength was seen after 
17 weeks of resistance training when compared to controls. The same study showed that 
while aerobic training did not result in improved strength, improvements in aerobic 
fitness and body composition were seen in comparison to the control group (Courneya et 
al., 2007). A study by Quist et al. (2012) combined high intensity aerobic training with 






only six weeks of training. A number of other investigations have shown increases in 
muscular strength following a physical activity intervention in cancer survivors both 
during and after treatment (Adamsen et al., 2009; Battaglini et al., 2007; Hagstrom et al., 
2016; Jarden, Baadsgaard, Hovgaard, Boesen, & Adamsen, 2009; Oldervoll et al., 2011; 
Schmitz et al., 2009; A. L. Schwartz & Winters-Stone, 2009; A. L. Schwartz, Winters-
Stone, & Gallucci, 2007; Strasser, Steindorf, Wiskemann, & Ulrich, 2013). In contrast, 
several other studies showed no significant increase in muscular strength following a 
physical activity intervention (Coleman et al., 2003; Mustian et al., 2009; Wiskemann et 
al., 2011); however, these interventions were also home-based, unsupervised 
interventions.   
 In addition to increases in muscular strength, a body of evidence shows resistance 
training increases muscle mass in cancer patients; however, the evidence is not as clear as 
it is for strength. Prostate cancer patients have shown increases in muscle mass between 
0.8 – 1.7 kg (Hanson et al., 2012; Segal et al., 2009) and breast cancer patients increased 
muscle mass by 0.8 kg during chemotherapy (Courneya et al., 2007) following a 
resistance training intervention. Several other investigations have shown increases in 
muscle mass and volume following a combined aerobic and resistance exercise 
intervention (Battaglini et al., 2007; Coleman et al., 2003). In contrast, several other 
studies showed no significant increases in muscle mass following a resistance training 
intervention in cancer survivors; however, one of these studies only involved a four week 
intervention (Cunningham et al., 1986) and the other two were home based interventions 
(Demark-Wahnefried et al., 2008; Mustian et al., 2009). At this time, there are no 






However, there are three ongoing studies looking to evaluate this topic (Christensen et 
al., 2014; L. W. Jones, Douglas, et al., 2010; L. W. Jones, Eves, et al., 2010; Thorsen et 
al., 2012). Overall the evidence is stronger for increased muscular strength in the absence 
of muscular hypertrophy indicating improvements in strength may be partly attributable 
to improved neural adaptations and motor unit activation (J. C. Brown, Winters‐Stone, et 
al., 2012; Christensen et al., 2014). 
Two studies examined strength outcomes following an aerobic only intervention 
in cancer patients. Both investigations showed significant decreases in muscular strength 
(Baumann, Kraut, Schule, Bloch, & Fauser, 2009; Mello, Tanaka, & Dulley, 2003). 
While aerobic exercise does not have as large an impact on increasing muscle mass or 
strength in cancer patients, it has shown to improve overall physical function, 
psychological function, reduce inflammation, reduce cardiotoxicities, and improve 
prognosis which are also important factors for cancer survivors (Christensen et al., 2014; 
L. W. Jones et al., 2009).  
This review of literature reveals the need to for continued research into the 
mechanisms, treatment, and assessment methods surrounding CRF. Enhancing our 
understanding of muscle function and how it relates to CRF can assist clinicians in 
designing the appropriate exercise program for survivors experiencing this phenomenon. 
Furthermore, understanding the effects of exercise on muscle fatigue in this population 













Study procedures were approved by the University of Northern Colorado’s (UNC) 
Institutional Review Board (see Appendix A). Participants in this study were 155 males 
and females over the age of 18 who had been previously diagnosed with cancer. 
Participants were referred to the University of Northern Colorado Cancer Rehabilitation 
Institute (UNCCRI) from local oncologists as individuals who were either undergoing or 
had undergone chemotherapy, radiation, surgery, immunotherapy or a combination of 
treatments. Prior to participation, individuals were informed of the study procedures and 
signed an informed consent to participate in an initial assessment in addition to exercise 
training (see Appendix B). A separate informed consent specific to this study was signed 
by participants (see Appendix C).  
Procedures 
Medical history was obtained prior to the initial assessment and included cancer 
type, stage, medications, and all treatments. Cancer survivors completed three different 
initial assessments of fatigue including measurements of self-reported and physiological 
fatigue. Anthropometric data were also collected. Height was measured by a digital free-
standing stadiometer (InBody, Cerritos, CA). Weight and body composition were 
measured by bioelectrical impedance (In-Body, Cerritos, CA). Scores of subjective 






CRF (PFST), as well as subscales of fatigue including sensory, affective, behavior, 
cognitive and mood. The individual subscales together consist of 22 questions with the 
average score representing total fatigue. Each of the 22 questions was scaled from 0 to 
10. A score of 0 indicated that the patient was not experiencing any fatigue, a score of 1 
to 3 indicated mild fatigue, a score from 4 to 6 indicated moderate fatigue, and a score of  
>7 indicated severe fatigue. The PFS has been shown to be valid and reliable measure of 
CRF in cancer patients (Piper et al., 1998).  
The behavioral/severity subscale (PFSB) included six questions that assessed the 
impact of fatigue on school/work, social interaction, and the overall interference with 
enjoyable activities. The affective (PFSA) subscale included five questions that assessed 
the extent to which fatigue affects emotional meaning. The sensory (PFSS) subscale 
included five questions that assessed mental, physical, and emotional symptoms of 
fatigue. The cognitive/mood subscale (PFSC) included six questions that assessed the 
impact of fatigue on concentration, memory, and mental clarity (Piper et al., 1998) (see 
Appendix D) 
Following completion of the PFS, assessment of hand grip fatigue was conducted 
through the use of a hand dynamometer. The use of a hand dynamometer has been shown 
to be a valid and reliable method to measure handgrip strength in cancer patients (D. J. 
Brown, McMillan, & Milroy, 2005; Innes, 1999; Trutschnigg et al., 2008). The 
dynamometer (Layfayette/TEC, Layfayette IN) handle was first sized to correctly fit the 
hand of the participant. Muscular fatigue was measured using a protocol of 15 maximum 
contractions at a rate of one contraction every two seconds. A metronome in addition to 






as well as a note of which was the dominant hand. Values in kilograms (kg) were 
recorded for each contraction and a fatigue index (FI) was calculated using the averages 
of the two highest and two lowest recorded values. Once the averages were calculated 
they were inserted into the following equation to determine fatigue index: FI (%) = 
[(highest – lowest)/highest]*100 (Beam & Adams, 2011).  
Following hand dynamometry assessment, participants were escorted to UNC’s 
Biomechanics Lab to participate in lower body muscular fatigue testing. Isokinetic torque 
of the knee extensor muscles was measured using a Biodex© dynamometer (Biodex 
Medical Inc., Shirley, NY). The use of isokinetic dynamometers has been shown to be 
valid and reliable (Drouin, Valovich-mcLeod, Shultz, Gansneder, & Perrin, 2004; Innes, 
1999) and has previously been used to measure lower body strength measurements in 
patients with cancer (Kilgour et al., 2010; Weber et al., 2009; Wilcock et al., 2008). 
Subjects were instructed to sit upright and the dynamometer was correctly fitted to each 
participant. The lateral femoral epicondyle was used as a landmark for positioning the 
knee joint with axis of rotation of the dynamometer. To prevent additional body 
movement, straps were used to secure the testing leg and trunk to the dynamometer chair. 
The testing leg was then secured to the leg attachment above the ankle. Range of motion 
was determined by having the participant extend and flex his or her leg as far as possible 
without discomfort. Correction for limb weight was obtained by measuring torque 
exerted on the dynamometer with the knee fully extended and relaxed. Subjects were 
instructed on the protocol and were be asked to give maximum effort for each repetition 
during each set of exercises. The first two sets consisted of five warm-up repetitions at 






by 90 seconds of rest. The third set served as the fatigue protocol which consisted of 15 
maximal repetitions at 60°/s. The dynamometer was then repositioned and the same 
procedures were performed on the opposite side. Throughout the test, visual and verbal 
encouragement was given by the test administrator. A familiarization session was 
conducted prior to the testing session to allow the participant to become familiar with the 
protocol. A minimum of two rest days was given between the familiarization protocol 
and the testing protocol. MATLAB® R2014a (Mathworks Inc., Natick, MA) was used to 
extract the data output from the Biodex© and identify peak torque from each repetition. 
The same method of determining FI for upper body (HFI) was used for the lower body 
(QFI).  
After completing the above pre-assessments, participants completed an 
individualized, prescriptive exercise intervention that took place at UNCCRI. Each 
exercise intervention was conducted by trained Cancer Exercise Specialists for three 
months within the standard UNCCRI program. At the end of each 12-week session, 
participants were again asked to complete the aforementioned battery of assessments to 
determine whether the 12-week intervention had any effects on functional performance.  
Intervention 
The exercise intervention consisted of a one-hour period that included aerobic 
training, resistance strength training, balance, and flexibility training. Each participant 
took part in the intervention no more than three times per week and on non-consecutive 
days. Each session included 20 minutes of aerobic training, 30 minutes of resistance 
training, and 10 minutes was set aside for flexibility. Aerobic and resistance training was 






UNCCRI has a phase program which consists of four phases. Entry into each phase 
depends on treatment status at entry into the program and subsequently completion of 12 
weeks of supervised training.  
An initial assessment to estimate maximal strength or one repetition maximum 
(1RM) was performed on the following resistance machines: chest press, shoulder press, 
seated row, lat pull down, leg extension, leg curl, and leg press. A percentage of the 
individual’s heart rate reserve (HRR) and estimated 1RM was used to prescribe exercise 
intensity for each 12 weeks of the program. Heart rate reserve is the difference between 
an individual’s maximum heart rate and their resting heart rate and the formula for 
calculating HRR is as follows: HRR = HRmax – HRrest. The formula for calculating 
exercise heart rate for a specific percentage of HRR is as follows: Exercise HR = % of 
target intensity (HRmax – HRrest) + HRrest. Using a percentage of HRR has been used as a 
common method of determining exercise intensity for prescriptive exercise (Karvonen, 
Kentala, & Mustala, 1957).  
Individuals still undergoing radiation or chemotherapy treatment were classified 
as Phase 1 and began at an intensity of 30-45% HRR and 1-RM. Individuals beginning 
the intervention for the first time that were not currently in treatment were classified as 
Phase 2 and began at 40-60% of their HRR and 1RM. Those individuals graduating from 
Phase 2 entered Phase 3 and began at 60-85% of their HRR and 1RM. Individuals 
graduating from Phase 3 entered Phase 4 and began at 65-95% of their HRR and 1RM.  
Progression of Phase 1 for the 12 weeks was 5% for cardiovascular training and 10-15% 
for muscular strength. Progression of Phase 2 was 10-20% for cardiovascular training and 






training and 30-50% for muscular strength. In Phase 4, progression aimed to be continual 
with an improvement of more than 5% in both cardiovascular endurance and muscular 
strength by the end of 12 weeks of training.  
Modes of aerobic exercise included the following: treadmill walking and running 
(Trackmaster ®TMX424, Jas Fitness Systems), walking outside, stationary bikes 
(Monark®), recumbent stepper (Nu Step®, BioStep®), AquaCiser (Ferno Aquaciser®II), 
and arm ergometer (SCIFIT®). Modes of resistance training included the following: 
weight machines (Cybex®), free weights (dumbbells), Thera bands (Power Systems® 
Versa Tubes®), body weight exercises, fitness balls (Gymnic® Fitball and Physio-Roll), 
and medicine balls (Power Systems®). Modes of balance exercise included dyna disc 
exercises, wobble disks, balance boards, Bosu® ball, and foam pad exercises. Flexibility 
training included static stretching, wall mounted range of motion wheel, and wall 
mounted stretching ropes. All exercise was supervised and heart rate and oxygen 
saturation were continuously monitored by Cancer Exercise Specialists and UNCCRI 
staff. Heart rate monitors (Polar®) were used to monitor heart rate and pulse oximeters 
were used to monitor oxygen saturation (Prestige Medical, Northridge, CA). Detailed 
records of each exercise session including heart rate, blood pressure, and oxygen 
saturation responses were documented by the Cancer Exercise Specialist for each 
participant. Safety of the participants during the exercise intervention was a top priority.  
Statistical Analysis 
 IBM® SPSS® Statistics version 23 (IBM® Armonk, NY) and SAS® version 9.4 
(Cary, NC) were used for all analyses. To determine if muscular fatigue was correlated to 






body fatigue indexes and total CRF scores (PSFT) as assessed though the revised Piper 
Fatigue Scale (PFS). Correlations between fatigue indexes and each of the four subscales 
of the PFS including sensory (PFSS), affective (PFSA), behavior (PFSB), and 
cognitive/mood (PFSC) was also made. Similarly, correlations were examined between 
peak quadriceps torque (PQF) (N.m) and PFST as well as between peak handgrip force 
(PHF) and each of the previously mentioned PFS subscales. R values and associated p 
values were used to determine correlation strength. To determine the effect of the 
exercise intervention on these same variables, a repeated measures multivariate analysis 
of variance (RMANOVA) was utilized following 12 and 24 weeks of exercise training. 
Planned contrasts evaluated pre-training to 12 weeks, 12 weeks to 24 weeks, and pre-
























RELATIONSHIPS BETWEEN MUSCULAR AND  
PSYCHOLOGICAL ASSESSMENT OF  
CANCER-RELATED FATIGUE  
 
Abstract 
Despite its prevalence, cancer-related fatigue (CRF) is seldom assessed and treated in 
clinical practice. The etiology of CRF has made the accurate assessment process a 
substantial challenge. Self-reported measures are widely used and accepted for CRF 
assessment, however, these are not objective measures of fatigue. Direct assessment of 
fatigue through functional testing of muscle could provide further insight into how cancer 
survivors experience fatigue, which could lead to improved exercise-based interventions 
that target this debilitating side effect of cancer and cancer treatments. PURPOSE: To 
evaluate the relationship between subjective self-reported fatigue measures and 
objectively-measured muscular fatigue in cancer survivors. METHODS: A total of 155 
cancer survivors (aged 60 ± 13 years) were asked to complete the revised Piper Fatigue 
Scale (PFS) which was composed of  a total CRF score (PFST) and four subscale scores: 
behavioral/severity (PFSB), affective (PFSA), sensory (PFSS), and cognitive/mood 
(PFSC). A handgrip fatigue index (HFI) composed of 15 maximal repetitions was 
completed by each participant. Participants also completed 15 maximal isokinetic knee 






fatigue index (QFI). Each fatigue index was computed as the difference between the 
average of the first two cycles and the average of the last two cycles divided by the 
average of the first two cycles and expressed as a percentage. RESULTS: Significant 
positive relationships between the HFI and PFST (r = .303; p < .001), PFSB (r = .287; p 
< .001), PFSA (r = .220; p < .001), PFSS (r = .352; p < .001), and PFSC (r = .301; p < 
.001) were observed. In addition, peak hand force (PHF) was significantly negatively 
correlated to PFST (r = -.177; p = .027), PFSB (r = -.209; p = .009) and PFSS (r = -.194, 
p = .015). No significant relationships were observed between PFS and QFI (r = -.034 p = 
.378). CONCLUSION: Results from this study suggest that objective measures of upper 
body fatigue, as measured though a hand dynamometer, are significantly related to 
subjective feelings of cancer-related fatigue (CRF) and could potentially serve as an 
objective measure of fatigue in cancer survivors. 
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An estimated 11 million cancer survivors are currently living in the United States. 
Due to increases in technology, improvements in treatment and detection methods, the 5-
year relative survival rates for all cancers have been gradually improving over the last 
few decades (R. Siegel, J. Ma, Z. Zou, & A. Jemal, 2014). Thus, individuals diagnosed 
with cancer are living longer following treatment which has resulted in a greater number 
of cancer survivors living longer following treatment. Despite decreases in mortality, 
survivors still suffer from the side effects from of chemotherapy, radiation, surgery, 
hormone therapy, or a combination of these treatments. Cancer treatment is known to 
negatively affect many dimensions of an individual’s life including decreased functional 
capacity and increased fatigue (J. C. Brown, Winters‐Stone, et al., 2012).  
Cancer survivors frequently report one or more symptoms that affect quality of 
life, with the most commonly reported symptom being cancer related fatigue (CRF). 
Fatigue is a difficult symptom to define and can include at least two different dimensions. 
The first dimension is a subjective state of fatigue and characterized by a feeling of 
weakness and a perception of a decreased ability to perform physical tasks. The second 
dimension can be defined as an objective measure of decrement in mental or physical 
performance due to a repeated or prolonged activity. This decrement of performance has 
also been associated as a common symptom with various chronic diseases. Cancer related 
fatigue is different in that it is characterized by extreme exhaustion that is not related to 
activity (P. C. Stone et al., 1998). Other evidence has suggested that cancer patients could 
experience three dimensions of fatigue including cognitive, affective, and physical 






Several mechanisms underlying CRF have been proposed; however, the 
pathophysiology is still largely unknown (Saligan et al., 2015). Tumor factors and 
cytokines associated with cancer biology and treatments may influence increases in 
protein degradation in cancer survivors that is associated with loss of muscular strength 
(Cantarero-Villanueva et al., 2012). Skeletal muscle structure and function is negatively 
affected by both the cancer itself and its treatment modalities, and fatigue is understood 
also to be caused by both mechanisms. In addition to mechanisms underlying muscular 
fatigue, other theories exist regarding CRF that are independent of muscular function 
including the following: dysregulation of circadian rhythm, hypothalamic-pituitary-
adrenal-axis, anemia, vagal-afferent activation, and ATP regeneration (Ryan et al., 2007; 
Saligan et al., 2015; X. S. Wang, 2008). Clinical studies have investigated factors related 
to both treatment and the disease including pain, depression, anxiety, cachexia, as well as 
other psychological and physical conditions. Despite these investigations there is still 
little understanding into reliable physiological markers as objective fatigue measures (X. 
S. Wang, 2008). Overall, the dimensions of CRF seem to involve the dysregulation of 
physiological, biochemical, and psychological mechanisms (Ryan et al., 2007; Weis & 
Horneber, 2015). 
As many as 95% of cancer patients report CRF as a symptom from the cancer 
itself or due to the side effects of treatment. Despite its prevalence, CRF is seldom 
assessed and treated in clinical practice (Portenoy & Itri, 1999; Weis & Horneber, 2014). 
Due to the subjective and multifactorial causes of CRF, accurate assessment is a 
significant challenge. Currently, self-report measures are widely used and generally 






psychological fatigue. While multidimensional surveys attempt to assess a physical 
fatigue dimension, outcomes are still of a subjective nature. Numerous studies in cancer 
patients have reported a strong relationship between fatigue and psychological stress such 
as depression and reduced quality of life (Blakely et al., 1991; L. F. Brown & Kroenke, 
2009; Bruera et al., 1989; Derogatis et al., 1983; P. C. Stone et al., 1998; Visser & Smets, 
1998). However, psychological stress alone cannot explain most of the fatigue felt by 
cancer patients. Considering fatigue is the most frequent symptom experienced by 
patients with cancer, an accurate measure of CRF is critical to understanding the science 
behind fatigue and to aid in assessment and treatment strategies (P. C. Stone et al., 1998).  
Because grip strength is related to many activities of daily living, it is often used 
in clinical settings to assess overall strength (Nicolay & Walker, 2005). Handgrip 
strength has been shown to be decreased in colorectal and prostate cancer patients; 
however, more research is needed to better understand whether handgrip strength can be 
used as an indicator of fatigue in cancer survivors (Cantarero-Villanueva et al., 2012). 
Considering most daily activities require continuous, dynamic movements rather than 
continual static holding as assessed in maximum grip strength, testing of handgrip 
endurance may be a better indicator of fatigue than maximal grip strength. Few studies 
have yet to examine measurements of dynamic grip endurance, and no study was found 
that compared psychological fatigue measurements to handgrip fatigue.  
Exertional fatigue has been shown to have a negative association with skeletal 
muscle mass and strength; however, it is still unknown if there is an association with 
these variables and CRF (Kilgour et al., 2010). Additionally, there is evidence linking 






(Dimeo, 2001; Tian et al., 2016; Velthuis et al., 2010). Considering what is currently 
known about CRF and cachexia, it is surprising that a relationship between muscular 
strength or muscle mass and CRF has yet to be established. Linking muscle parameters 
and CRF might partially, yet effectively explain the degree of exhaustion felt by cancer 
survivors (Kilgour et al., 2010). 
Since fatigue seems to be associated with a physiological component, a growing 
number of studies are investigating physical activity as a treatment intervention. Exercise 
training has been reported to be beneficial in cancer survivors as it improves functional 
capacity and muscular strength (van Weert et al., 2006). Physical activity has been shown 
to reduce fatigue (Haas, 2011; M. E. Schmidt et al., 2012; Schneider et al., 2007a, 2007b) 
and increase strength (Courneya et al., 2007; Segal et al., 2003; Speck et al., 2010). As 
mentioned, there is a substantial amount of evidence linking physiological mechanisms to 
CRF (Ryan et al., 2007; Saligan et al., 2015; X. S. Wang, 2008; Weis & Horneber, 2015). 
Therefore, it is interesting that current assessments leave out the evaluation of a 
physiologic component that could be a contributing factor.  
Considering the multi-dimensional causes of fatigue, an accurate measure of 
physiological fatigue is also necessary to determine best treatment methods (P. C. Stone 
& Minton, 2008). The relationships, however, between in self-reported fatigue and 
muscular fatigue have yet to be investigated. Considering the development cancer-
specific subjective fatigue scales, it is of interest to consider the physiological origin of 
CRF. In addition, a lack of research exists in the area of muscular and physiological 






Therefore, the purpose of this study was to evaluate the relationship between objectively-
measured muscular fatigue and self-reported psychological fatigue.   
Methods 
Study procedures were approved by the University of Northern Colorado’s (UNC) 
Institutional Review Board. Participants in this study were males and females over the 
age of 18 who had been previously diagnosed with cancer. Participants were referred to 
the University of Northern Colorado Cancer Rehabilitation Institute (UNCCRI) from 
local oncologists as individuals who were either undergoing or had undergone 
chemotherapy, radiation, surgery, hormone therapy, immunotherapy or a combination of 
treatments. Current participants in the UNCCRI program were also recruited prior to their 
re-assessment within the program. Written and verbal study information was given to 
subjects before participation. An informed consent was then signed by participants. 
Medical history consisting of cancer type, stage, and treatments were obtained prior to 
assessments. Anthropometric data were collected during the patient’s initial assessment 
which included age, height, weight, and body composition. Body composition was 
analyzed by the use of bioelectric impedance (InBody, Cerritos, CA) 
A total of 155 cancer survivors (60 ± 13 years of age) completed three different 
initial assessments of fatigue including both measurements of psychological and 
physiological fatigue. Scores of fatigue were established via the revised Piper Fatigue 
Scale (PFS) which is a multidimensional scale to evaluate total CRF as well as subscales 
of fatigue including sensory, affective, behavior, cognitive and mood (Piper et al., 1998). 
The individual subscales together consist of 22 questions with the average score 






of 0 indicates that the patient was not experiencing any fatigue, a score of 1 to 3 indicates 
mild fatigue, a score from 4 to 6 indicates moderate fatigue, and a score of > 7 indicates 
severe fatigue. The behavioral subscale (PFSB) included six questions that assessed 
impact of fatigue on school/work, social interaction, and the overall interference with 
enjoyable activities. The affective (PFSA) subscale included five questions that assessed 
fatigue affected emotional meaning. The sensory (PFSS) subscale included five questions 
that assessed mental, physical, and emotional symptoms of fatigue. The cognitive/mood 
subscale (PFSC) included six questions that assessed fatigue impact on concentration, 
memory, and mental clarity. The PFS has been shown to be a valid and reliable measure 
of CRF in cancer patients (Piper et al., 1998). 
Following completion of the PFS, participants completed an assessment of upper 
body fatigue using a hand dynamometer protocol consisting of 15 repetitions requiring 
maximal voluntary effort. The dynamometer (Layfayette/TEC, Lafayette IN) handle was 
first sized to correctly fit the hand of the participant and the dominant hand was identified 
as the hand used for writing. With a metronome set to the a pace of 60 beats per minute, 
participants were instructed to squeeze the hand dynamometer as hard as possible while 
maintaining the constant pace of one repetition every other beat until 15 repetitions were 
completed. The task was then repeated on the opposite hand. Values in kg were recorded 
and a fatigue index (FI) was calculated using the averages of the two highest and two 
lowest recorded values. Once the averages were calculated they were put into the 
following equation to determine fatigue index: FI (%) = [(highest – lowest)/highest]*100.  
Following hand dynamometry assessment, participants were asked to complete 






measured on a Biodex© (Biodex Medical Inc., Shirley, NY) dynamometer. Subjects sat 
upright and were fitted to the dynamometer using the lateral femoral epicondyle as a 
landmark for positioning the knee joint with axis of rotation of the dynamometer. To 
prevent additional body movement, straps were used to secure the testing leg and trunk to 
the dynamometer chair. Correction for limb weight was obtained by measuring torque 
exerted on the dynamometer with the knee fully extended and relaxed. Subjects were 
instructed to give maximum effort for each repetition during each set of exercises and 90 
seconds of rest was given between sets. The first two sets consisted of five warm-up 
repetitions at speeds of 180°/s and 120°/s, respectively. The third set consisted of the 
fatigue protocol and consisted of 15 repetitions at 60°/s. The dynamometer was then 
repositioned and the same procedures were performed on the opposite side. A 
familiarization session was conducted prior to the testing session to allow the participant 
to become familiar with the protocol. Dominant limb was determined at the 
familiarization session by asking the participant which leg they would use to kick a ball. 
A minimum of two rest days were given between the familiarization protocol and the 
testing protocol. 
 MATLAB® R2014a (Mathworks Inc., Natick, MA) was used to analyze Biodex© 
data output and identify peak torque (N.m) from each repetition. The same method of 
determining FI for upper body (HFI) was used for the lower body (QFI). Lean muscle 
mass was determined by body fat percentage and body weight. IBM® SPSS® Statistics 20 







Data are presented as means ± SD. While both dominant and non-dominant limbs 
were tested, only dominant limb data were used for the analysis. Initial characteristics of 
participants are listed in Table 1. Treatment history and clinical characteristics are 
presented in Table 2. Fatigue indices, muscular strength, and muscle mass for all subjects 
are presented in Table 3. Lastly the individuals in each fatigue classification are presented 
in Table 4. 
Table 1 
















Age in years (mean ± SD)  60 ± 13 
Mass in kg (mean ± SD) 77 ± 19 
Height in cm (mean ± SD) 165 ± 14 
Female (n) 97 
Male (n) 58 






Table 2  
Treatment History and Clinical Characteristics 
Variables n       % 
Cancer stage   
0 2  1 
I 39  25 
II 46  30 
III 41 26 
IV 26 17 
Chemotherapy    
Yes 113 73 
No 42 27 
Radiation   
Yes 86 55 
No 69 45 
Surgery   
Yes 122 79 
No 33 21 
In-treatment 19 12 
Out of treatment  136 88 




Muscle Mass, Strength, and Fatigue 
Variables Mean ± SD 
Lean muscle mass (kg) 51 ± 13 
Handgrip strength (kg) 18 ± 7 
Quadriceps strength (N.m) 150 ± 53 
Hand fatigue index (%) 33 ± 16 








Table 4  
PFS Fatigue Classifications 






Higher PFST scores showed a significant moderate correlation with higher HFI (r 
= .303, p < .001). Significant correlations between the HFI and PFS subscales PFSB (r = 
.287; p < .001), PFSA (r = .220; p < .001), PFSS (r = .352; p < .001), and PFSC (r = 
.301; p < .001) were also observed. Peak hand force (PHF) was significantly negatively 
correlated to PFST (r = -.177; p = .027), PFSB (r = -.209; p = .009) and PFSS (r = -.194, 
p = .015). Fatigue indices of the hand and quadriceps were not significantly correlated to 
each other (r = .021, p = .791); however, PHF and peak quadriceps force (PQF) were 
significantly positively correlated (r = .198, p = .014). More advanced cancer stage 
showed significant correlations with PFST (r = .181; p = .025), PFSA (r = .212; p < 
.001), PFSS (r = .185; p = .022), and PFSC (r = .160; p = .048) but none of the fatigue 
indices. Cancer stage also showed significant positive correlations with PHF (r = .235; p 
= .002) and lean muscle mass (LMM) (r = .214; p = .011). LMM also showed a 
significant positive correlation with PHF (r = .206; p = .010) and PQF (r = .601; p < 
.001). QFI was not significantly correlated to PFST (r = -.034, p = .678) or any of the 
PFS subscales. A correlation matrix representing all dependent variables is shown in 



































Hand Fatigue Index (%)
Figure 1 represents the correlation between HFI and PFS while Figure 2 









Figure 1. Scatterplot of hand fatigue index versus total Piper Fatigue Scale scores. Dotted 
line represents the line of best fit. 
Table 5 
Pearson Correlation Matrix for Main Study Variables 
  
 PFSB PFSA PFSS PFSC HFI  QFI  PHF PQF LMM Stage 
PFST .918** .923** .911** .904** .303** -.034 -.177* -.112 
33 
.069 .181* 
PFSB  .794** .778** .745** .287** -.037 -.209** -.126 .081 .155 
PFSA   .816** .797** .220** -.034 -.134 -.105 .037 .212** 
PFSS    .803** .352** -.021 -.194* -.091 .089 .185* 
PFSC     .301** -.018 -.109 -.097 .021 .160* 
HFI      -.021 -.525** -.004 .012 .053 
QFI       -.108  .070 -.096 .034 
PHF         .198* .206* .235** 
PQF         .601** .119 
LMM          .214** 
* Correlation is significant at the .05 level (2-tailed) 
** Correlation is significant at the .01 level (2-tailed) 
 
  















Figure 2. Scatterplot of quadriceps fatigue index versus total Piper Fatigue Scale scores. 
Dotted line represents the line of best fit. 
Discussion 
Several studies have reported observed reductions in muscle mass and function 
due to cancer and its treatments (Christensen et al., 2014; Kilgour et al., 2010; Weber et 
al., 2009). The relationship, however, to muscle function and subjective feeling of fatigue 
remains unclear and was supported by this study which showed that upper body local 
muscular fatigue was associated with CRF.  
Results from this present study show that muscular fatigue of the upper body as 
assessed by handgrip measures is significantly correlated to subjective feelings of fatigue. 
Results showed a small to moderate correlation between higher levels of subjective 
fatigue and upper body measures of fatigue. Additionally, higher levels of handgrip 
strength were significantly associated with lower subjective feelings of fatigue. No 
significant relationships were found between lower body fatigue measurement, lower 
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fatigue and lower body fatigue relationships may be due to the number of survivors 
diagnosed and treated for cancers which largely affect strength of the upper body, such as 
breast cancer. Results from this study also show that cancer stage is not related to 
muscular fatigue measures but shows a significant relationship with subjective fatigue 
scores. Increases in cancer stage were positively associated with higher levels of lean 
mass. Among participants in this study, it does not appear that more malignant diagnoses 
resulted in decreases in muscle mass. This result is not in agreement with other studies 
indicating those with more advanced stages of cancer have lower levels of muscle mass 
(Cao et al., 2010; Freedman et al., 2004; Greenspan et al., 2005; Reis et al., 2009). While 
some relationship appears to exist between stage what cancer stage and type of 
malignancy, these alone cannot explain a majority of the fatigue variation reported by 
individuals (P. Stone, Richards, A'hern, & Hardy, 2000).  
A similar study by Kilgour et al. (2010) evaluated whether CRF was associated 
with skeletal muscle mass as well as upper and lower body muscular strength in advanced 
cancer. Results from our study are similar to that of Kilgour et al. (2010) who found that 
lower levels of both handgrip strength and leg strength were found to be associated with 
higher levels of CRF in patients with advanced cancer; however, results from our study 
were not significant for lower body measures. Handgrip and Biodex lower body 
measurements were used similarly to the present study; however, outcome measures were 
maximal strength rather than fatigue index. Additionally, the present study did not focus 
on advanced staged cancer but rather all stages. Results from Kilgour et al. (2010) found 
lower levels of lean body mass to be related to higher levels of CRF; however, this 






Similar to this study, correlations between isometric handgrip strength and fatigue 
have been observed in other studies in the cancer population (P. Stone et al., 2000; K. M. 
Winters-Stone, Bennett, Nail, & Schwartz, 2008). Results from this study are in contrast 
to others who found no correlation between handgrip strength and subjective fatigue 
measurement (D. J. Brown et al., 2005; P. Stone, Hardy, Broadley, Kurowska, & A'Hern, 
1999). It is important to note, however, that this was the first known study to use a 
dynamic assessment and compute a fatigue index rather than maximal strength or 
isometric testing in comparison to subjective CRF scores. 
Relationships between lower body strength/fatigue and subjective feelings of 
fatigue have received very little attention in the cancer population as the aforementioned 
studies used only handgrip strength as a measure of muscle function. Two other known 
studies have assessed quadricep strength in cancer survivors (Weber et al., 2009; Wilcock 
et al., 2008) with only one other study (Kilgour et al. 2010) comparing both quadriceps 
strength and a subjective fatigue measures. Other studies have utilized functional tests 
such as the sit-to-stand (D. J. Brown et al., 2005; K. M. Winters-Stone et al., 2008) and 
found correlation with subjective fatigue. Additionally, studies have also used the 6-
minute walk test (Toth et al., 2013) and the 12-minute walk tests as measures of lower 
body fatigue (K. M. Winters-Stone et al., 2008). The current study is the only study 
known to use an objectively measured lower body fatigue measurement in this population 
rather than using strength or endurance tests as an outcome. 
Fatigue is a common adverse side effect of cancer and its therapy. However, 
specific physiological mechanisms underlying CRF remain unclear. Some proposed 






cytokines, detraining, anemia, and muscle wasting (Ryan et al., 2007; Saligan et al., 
2015). Cancer-related cachexia is common in cancer patients and is characterized by 
muscle wasting due to cancer treatments and reduced activity. Significant muscle wasting 
affects approximately 50% of individuals with cancer (Fearon et al., 2011). While we did 
not screen for cachexia, muscle mass was not related to either subjective or physiological 
fatigue measures. In contrast, individuals in this study who had been diagnosed with 
more advanced stages of cancer had higher amounts of muscle mass.  
There is no universally accepted standard for CRF measurement yet all current 
CRF measurement tools exist in self-report format. When assessing CRF both subjective 
and objective data should be included; however at this time there is not a validated 
objective CRF measurement. One limitation to this study is that only one self-report 
measurement was used in the PFS. While in practice, the PFS is used to assess CRF over 
a variety of cancers, it was originally developed and validated for breast cancer survivors. 
Perhaps a different survey evaluation would more closely correlate to muscular fatigue 
than the PFS. Despite these limitations with the survey, it has been shown to be the most 
comprehensive and multi-dimensional method available for use as a research instrument 
in the cancer population (Ahlberg et al., 2003).  
Recent research has focused on determining whether CRF is more expressed as 
peripheral fatigue versus central fatigue. The cause of peripheral fatigue is failure of the 
muscle contraction mechanism or metabolic changes within the muscle. Central fatigue is 
caused by loss of muscle contraction due to mechanisms involved in the neuromuscular 
junction and communication between the neuron and the muscle (Yavuzsen et al., 2009). 






fatigue is that peripheral fatigue was tested in this study, while other studies suggest that 
central fatigue may play a larger role in CRF than peripheral fatigue (Kisiel-Sajewicz et 
al., 2012; Yavuzsen et al., 2009). Further evidence is needed however to confirm 
physiological mechanisms in muscular CRF.  
It is possible that the lack of a meaningful relationship between subjective and 
physiological fatigue measures of the lower body could be due to voluntary activation. 
Submaximal activation (i.e., an inability to maximally activate muscle) is not uncommon 
in adults despite the inclusion of verbal encouragement. A study by Nordlund, 
Thorstensson, and Cresswell (2004) found a large variability in voluntary activation 
suggesting that individuals who cannot fully activate their muscles may fatigue less but 
are also able to generate much less force and power. Additionally, a common observation 
when examining fatigue is that those who can generate a higher force generally fatigue 
quicker. Despite this information we did not observe such a phenomenon in this 
population. Individuals who had a higher peak force of both the hand and quadriceps 
showed lower amounts of both subjective and muscular fatigue, which was consistent 
with our hypothesis.  
Many clinicians rely on subjective, self-reported measures for outcomes of CRF. 
A number of theorized CRF fatigue mechanisms; however, are known to be caused by 
physiological mechanisms. Therefore a physical measure of fatigue, in addition to the 
self-reported measures, may enhance the clinician’s assessment of CRF. This is important 
considering cancer-specific assessments of fatigue directly dictate the exercise 
prescription and dosage of exercise prescribed for cancer survivors. By having more 






to enhance the efficacy of exercise-based cancer rehabilitation programs. Results from 
this study found a quick and easy to adminsiter handgrip assessment to be a superior 
objective measure to a more lengthy isokinetic assessment that also requires large and 
expensive equipment.  
The majority of subjects in this study reported mild-to-moderate CRF in regards 
to self-reported measures. An additional limitation of this study is the number of subjects 
currently undergoing chemotherapy and radiotherapy. CRF is experienced to the greatest 
extent during treatment and many physiological impairments lessen as time from 
treatment increases. This could have contributed to the muted HFI and QFI results.  
In summary, upper body muscular fatigue as assessed though handgrip measures 
are correlated with subjective CRF experienced by cancer survivors. Future studies 
should evaluate changes in PFS and CRF following an exercise intervention. Further 
investigation into whether CRF is more related to central or peripheral mechanisms is 
also warranted. Finding the optimal method for treating CRF remains an important 
research topic. It is still believed that due to the physical mechanisms associated with 
CRF, a secondary physiological measure of fatigue is needed. Continued investigation 
into muscular dysfunction and its relationship to CRF may assist clinicians in 
individualizing treatment methods and further our understating of mechanisms and the 
pathophysiology that causes CRF in cancer survivors.  
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EFFECTS OF EXERCISE TRAINING ON PHYSIOLOGICAL  
AND PSYCHOLOGICAL MEASUREMENTS OF 
CANCER-RELATED FATIGUE  
 
Abstract 
The effect of exercise on objectively measured muscular fatigue has yet to be studied in 
cancer patients. Evaluating how exercise modulates psychological and physiological 
fatigue dimensions either similarly, or differently, could aid in our understanding of how 
exercise reduces fatigue in cancer patients. PURPOSE: To evaluate the relationship 
between subjective self-reported psychological fatigue measures and objectively-
measured muscular fatigue in cancer survivors following a 24 week exercise intervention. 
METHODS: A total of 21 cancer survivors (62 ± 14 years of age) were asked to 
complete both physiological and psychological measures of fatigue prior to and following 
the exercise intervention. Participants completed the revised Piper Fatigue Scale (PFS) 
which produces a total score (PFST) and four subscale scores: behavioral/severity 
(PFSB), affective (PFSA), sensory (PFSS), and cognitive/mood (PFSC). A handgrip 
fatigue index (HFI) was determined for each participant by repetitively squeezing a 
handgrip dynamometer 15 times with maximal force for each repetition. Participants also 
completed 15 maximal force knee extensions at a joint angular velocity of 60 deg∙s-1 and 






difference between the average of the first two cycles and the average of the last two 
cycles divided by the average of the first two cycles and expressed as a percentage. 
Following testing, participants completed 24 weeks of supervised exercise training. 
Fatigue testing was performed following 12 and 24 weeks of the exercise intervention. 
RESULTS: Significant main effects were found for PFST and all four subscales (p < 
.05). No significant main effects were found for either muscular fatigue measures or peak 
force. Results indicate significant decreases in PFST (p = .001), PFSB (p = .015), PFSA 
(p = .001), PFSS (p = .001), and PFSC (p = .004) following 12 weeks of the exercise 
intervention. In addition, there were no statistically significant changes observed in either 
measures of objective fatigue HFI (p = .606), QFI (p = .455), peak handgrip force (PHF) 
(p = .621) or peak quadriceps force (PQF) (p = .091). Testing following 24 weeks of the 
intervention resulted in significant decreases in PFST (p = .031), PFSA (p = .023), and 
PFSS (p = .016). CONCLUSION: Following exercise training there was a significant 
decrease in subjective fatigue scores (PFST) but not muscular fatigue measures (HFI and 
QFI). Exercise was shown to decreases subjective fatigue more significantly than 
objective measures of fatigue possibly indicating that exercise may modulate dimensions 















An estimated 1.6 million new cases of cancer will have been diagnosed in the 
United States in 2015 (Siegel et al., 2015). Treating cancer is often challenging and 
involves techniques including surgery, radiation, chemotherapy, immunotherapy, 
hormone therapy, or various combinations of treatments. Type of treatment is dependent 
on a wide variety of factors including cancer type, stage, and location. Cancer treatments 
are generally known to negatively affect many dimensions of an individual’s life and may 
include decreased endurance, decreased muscular strength, and increased fatigue. In 
addition, side effects may include decreased bone density, cardiotoxicity, cognitive 
defects, and pulmonary dysfunction (J. C. Brown, Winters‐Stone, et al., 2012). The 
majority of cancer patients experience one or more side effects or symptoms during and 
following treatment, with the most common being pain, emotional distress, and fatigue. 
The management of side effects from cancer treatment is an important aspect of patient 
care, and can positively influence quality of life in addition to psychological and physical 
functioning (Siegel et al., 2012).  
Cancer-related fatigue (CRF) is the most common symptom reported by cancer 
survivors and it is estimated that as many as 96% of cancer survivors report CRF as a 
side effect of cancer treatment (Mock et al., 2000; Morrow et al., 2002). CRF is 
characterized by extreme fatigue and exhaustion and has a considerable negative effect 
on quality of life (Mock et al., 2000; Wagner & Cella, 2004). The impact of CRF on a 
patient’s functional capacity can be significant, and is one of the most distressing of 
reported symptoms (Hofman et al., 2007). CRF has been reported among wide ranges of 






initiated by a specific cancer type or treatment, suggesting that unknown physiological 
mechanisms may be responsible for the physical manifestations observed among patients 
with CRF (Hofman et al., 2007).   
Muscular fatigue is commonly associated with exercise but is often times 
experienced as a secondary outcome to many health conditions, disease states, and cancer 
(Bogdanis, 2012). Several studies have indicated that a commonly observed reduction in 
muscle mass among cancer survivors and decreased functional capacity may result from 
cancer and its treatments (Christensen et al., 2014; Kilgour et al., 2010; Weber et al., 
2009). Inactivity can be a contributing factor and may lead to decreased muscle mass and 
strength as well as increased fatigability of patients (Bogdanis, 2012). Physical activity in 
these populations has been shown to increase muscular function and strength in addition 
to enhancing the ability of muscles to resist fatigue (Bogdanis, 2012; Hurley, Hanson, & 
Sheaff, 2011).  
Cancer and its side effects on skeletal muscle have been a topic of recent study. 
Overall, cancer and its treatments are known to cause skeletal muscle atrophy and 
weakness (Christensen et al., 2014). The prevalence of muscle atrophy and impaired 
functioning in the cancer population, makes it difficult to discern whether impairment is 
due to impaired contractility or a loss of the contractile components themselves (M. S. 
Miller et al., 2014). In addition, skeletal muscle atrophy is a significant side effect of 
cancer that greatly depends on the tumor type and stage of cancer. Cachexia is the term 
used to describe muscle and fat loss that occurs with various chronic disease states. This 
condition, due to cancer and/or its treatment, is termed cancer-related cachexia, and, 






interventions (Fearon et al., 2012; Fearon et al., 2011; Skipworth et al., 2007). Decreases 
in skeletal muscle mass have been shown to reduce contractile function, increase muscle 
weakness, and decrease aerobic capacity (Bogdanis, 2012). Because of the debilitating 
effects of cancer-related cachexia, interventions to combat muscle loss in cancer patients 
should be prioritized during the rehabilitation process (Der-Torossian et al., 2013). In 
addition to whole muscle contractile dysfunction, investigations into cellular and 
molecular mechanisms suggest intrinsic skeletal muscle dysfunction at the level of the 
myofilament in cancer patients. While the research is limited, at least a few investigations 
show that cancer-induced skeletal muscle contractile dysfunction is independent of 
muscle atrophy (Der-Torossian et al., 2013; Toth et al., 2013).    
Cancer survivors are frequently instructed by physicians and clinicians to limit 
physical activity as a management strategy to conserve energy expenditure. A growing 
body of evidence, however, indicates that cancer survivors who engage in regular 
physical activity during and following treatment experience a number of health benefits 
including increased functional capacity and reductions in fatigue (J. C. Brown et al., 
2011). In the cancer population, physical activity can attenuate multiple side effects of 
treatment, potentially reverse functional losses that occurred during treatment, aid in the 
prevention of long-term effects, reduce rates of recurrence, and increase survival rates (J. 
C. Brown, Winters‐Stone, et al., 2012; Siegel et al., 2012). Both aerobic and resistance 
exercise training have been reported to be beneficial in cancer survivors both during and 
after treatment and have been shown to reduce CRF (Adamsen et al., 2009; Arnold & 
Taylor, 2011; J. C. Brown et al., 2011; J. C. Brown, Huedo-Medina, et al., 2012; Dimeo, 






2011; Puetz & Herring, 2012; M. E. Schmidt et al., 2012; Schneider et al., 2007a, 2007b; 
van Waart et al., 2015; Velthuis et al., 2010; Wyrick & Davis, 2009), improve functional 
capacity (L. W. Jones et al., 2012; Macvicar et al., 1989; Vardar Yagli et al., 2015), and 
increase muscular strength (Courneya et al., 2007; Fong et al., 2012; A. L. Schwartz & 
Winters-Stone, 2009; Segal et al., 2003; R. L. Siegel et al., 2014; Speck et al., 2010; van 
Waart et al., 2015; van Weert et al., 2006) 
There is a large body of literature on aerobic exercise and its effects on CRF; 
however, there remains substantial variability in the outcomes. Overall, aerobic exercise 
appears to have a small but statistically significant positive effect, suggesting that aerobic 
exercise could be beneficial in reducing CRF (Tian et al., 2016; Velthuis et al., 2010). 
Resistance exercise is also known to improve muscular mass, strength, and function in 
cancer survivors (Al-Majid & Waters, 2008). Despite this knowledge, compared to the 
research on aerobic training and CRF, there are fewer studies that include only resistance 
training with CRF as an outcome. A recent meta-analysis by J. C. Brown, Huedo-Medina, 
et al. (2012) found that the greatest reductions in CRF occurred in patients who 
participated in moderate or higher intensity resistance exercise. Resistance training has 
shown to have a positive effect on CRF; however, as with aerobic exercise not all studies 
have shown significant results (J. C. Brown et al., 2011; Courneya et al., 2007; M. E. 
Schmidt et al., 2015; Segal et al., 2009). Guidelines for exercise in cancer patients as set 
forth by the American College of Sports Medicine (ACSM), include both aerobic and 
resistance exercise as part of a well-rounded exercise program (Schmitz et al., 2010). 
While not completely elucidated, a majority of investigations have shown a positive 






recommended guidelines, a rehabilitation program that includes a combination of aerobic 
and resistance exercise seems most efficacious in reducing CRF (Schmitz et al., 2010). 
While exploring the differences in psychological and physiological fatigue among 
cancer survivors is not completely novel, the relationship between muscle function and 
perceptions of fatigue in cancer survivors remains mechanistically unclear (Kilgour et al., 
2010). Considering the evidence that exercise reduces both CRF and muscular fatigue, it 
appears efficacious to evaluate both dimensions when examining fatigue outcomes 
following an exercise intervention in is population. Furthermore, the effect of exercise on 
objectively measured muscular fatigue has yet to be studied in cancer patients. Evaluation 
of how exercise modulates psychological and physiological fatigue dimensions either 
similarly, or differently, could aid in our understanding of how exercise affects fatigue in 
cancer patients. Therefore the purpose of this study was to evaluate the effect of exercise 
on physiologically measured muscular fatigue and psychological fatigue in cancer 
survivors following a 24 week exercise intervention.  
Methods 
Study procedures were approved by the University of Northern Colorado’s (UNC) 
Institutional Review Board. Subjects underwent comprehensive screening prior to 
inclusion in the study. Participants were males and females over the age of 18 who had 
been previously diagnosed with cancer. Participants were referred to the University of 
Northern Colorado Cancer Rehabilitation Institute (UNCCRI) from local oncologists. 
Individuals were either undergoing or had undergone chemotherapy, radiation, surgery, 
immunotherapy or a combination of treatments. Prior to participation, individuals were 






total of 21 cancer survivors (60 ± 13 years of age) completed pre, mid (12 weeks), and 
post (24 weeks) intervention assessments of fatigue. 
Procedures 
Medical history was obtained prior to the initial assessment which included 
cancer type, stage, medications, and all treatments. Anthropometric data were also 
collected including height, weight, and body composition. Cancer survivors completed 
three different initial assessments of fatigue including measurements of self-reported and 
physiological fatigue. Scores of subjective fatigue were established via the revised Piper 
Fatigue Scale (PFS) which evaluates total CRF (PFST), as well as subscales of fatigue 
including sensory, affective, behavior, cognitive and mood. The individual subscales 
together consisted of 22 questions with the average score representing total CRF. The 
PFS has been shown to be a valid and reliable measure of CRF in cancer patients (Piper 
et al., 1998). The behavioral/severity subscale (PFSB) assesses the impact of fatigue on 
school/work, social interaction, and the overall interference with enjoyable activities. The 
affective (PFSA) assesses the extent to which fatigue affects emotional meaning. The 
sensory (PFSS) measures mental, physical, and emotional symptoms of fatigue. Finally, 
the cognitive/mood subscale (PFSC) assesses the impact of fatigue on concentration, 
memory, and mental clarity (Piper et al., 1998). 
Following completion of the PFS, assessment of hand grip fatigue was conducted 
through the use of a hand dynamometer. The use of a hand dynamometer has been shown 
to be a valid and reliable method to measure handgrip strength in cancer patients (D. J. 
Brown et al., 2005; Innes, 1999; Trutschnigg et al., 2008). The dynamometer 






participant. Fatigue was measured using a protocol of 15 maximum contractions at a rate 
of one contraction every two seconds. A metronome in addition to verbal cues and 
encouragement was used to keep participants on pace. Both left and right hands were 
recorded as well as a note of which is the dominant hand. Values in kilograms (kg) were 
recorded for each contraction and a fatigue index (FI) was calculated using the averages 
of the two highest and two lowest recorded values. Once the averages were calculated 
they were inserted into the following equation to determine fatigue index: FI (%) = 
[(highest – lowest)/highest]*100 (Beam & Adams, 2011).  
Following hand dynamometry assessment, participants were asked to complete 
lower body muscular fatigue testing. Isokinetic torque (N.m) of the knee extensor 
muscles was measured using a Biodex© dynamometer (Biodex Medical Inc., Shirley, 
NY). Use of isokinetic dynamometers has been shown to be valid and reliable (Drouin et 
al., 2004; Innes, 1999) and has previously been used to measure lower body strength 
measurements in patients with cancer (Kilgour et al., 2010; Weber et al., 2009; Wilcock 
et al., 2008). Subjects were asked to sit upright and while the dynamometer was adjusted 
to fit each participant. To prevent additional body movement, straps were used to secure 
the testing leg and trunk to the dynamometer chair. The testing leg was then secured to 
the leg attachment above the ankle. Range of motion was determined by having the 
participant extend and flex their leg as far as possible without discomfort. Correction for 
limb weight was obtained by measuring torque exerted on the dynamometer with the 
knee fully extended and relaxed. Subjects were instructed on the protocol and were asked 
to give maximum effort for each repetition during each set of exercises. The first two sets 






of the warm-up sets were followed by 90 seconds of rest. The third set served as the 
fatigue protocol which consisted of 15 maximal repetitions at 60°/s. The dynamometer 
was then repositioned and the same procedures were performed on the opposite leg. 
Throughout the test, visual and verbal encouragement was given by the test administrator. 
A familiarization session was conducted prior to the testing session to allow the 
participant to become familiar with the protocol. A minimum of two rest days were given 
between the familiarization protocol and the testing protocol. MATLAB® R2011a 
(Mathworks Inc., Natick, MA) was used to export the data output from the Biodex© and 
identify peak torque from each repetition. The same method of determining FI for upper 
body (HFI) was used for the lower body (QFI).  
After completing the above pre-assessments, participants completed an 
individualized, prescriptive exercise intervention that took place at UNCCRI. The 
exercise interventions were conducted by a trained Cancer Exercise Specialists for 24 
weeks within the standard UNCCRI Phase program. Participants were asked to complete 
the aforementioned battery of assessments following 12 and 24 weeks of the exercise 
intervention to determine whether exercise had any effect on measurements of functional 
performance and fatigue.  
Intervention 
The exercise intervention consisted of a one-hour period that included aerobic 
training, resistance strength training, balance, and flexibility training. Each participant 
took part in the intervention no more than three times per week and on non-consecutive 
days. Each session included 20 minutes of aerobic training, 30 minutes of resistance 






progressive and intensity was dependent on the treatment status of the participant. An 
initial assessment to estimate maximal strength or one repetition maximum (1RM) was 
performed on the following resistance machines: chest press, shoulder press, seated row, 
lat pull down, leg extension, leg curl, and leg press. A percentage of the individual’s heart 
rate reserve (HRR) and estimated 1RM was used to prescribe exercise intensity for the 
first 12 weeks of the program. Heart rate reserve is the difference between an individual’s 
maximum heart rate and their resting heart rate and the formula for calculating HRR is as 
follows: HRR = HRmax – HRrest. The formula for calculating exercise heart rate for a 
specific percentage of HRR was as follows: Exercise HR = % of target intensity (HRmax – 
HRrest) + HRrest. Using a percentage of HRR is a common method of determining exercise 
intensity for prescriptive exercise (Karvonen et al., 1957). Individuals still undergoing 
radiation or chemotherapy treatment began the program at an intensity of 30-45% HRR 
and 1RM. Individuals beginning the intervention that were not currently in treatment 
began exercise at 40-60% of their HRR and 1RM. For the first 12 weeks, progression for 
those individuals in treatment was 5% for cardiovascular fitness and 10-15% for 
muscular strength.  
Progression of individuals beginning exercise following treatment was 10-20% 
for cardiovascular fitness and 30-50% for muscular strength. Following 12 weeks of 
training, participant’s maximal strength was re-assessed and training intensity was 
increased to continue to progress the individuals from 12 to 24 weeks. Training intensity 
for the second 12 week session was 40-60% of HRR and 1RM for individuals who 
started the program in treatment with a progression intensity of 10-20% for 






second session for individuals who started the program out of treatment began at an 
intensity of 60-85% of HRR and 1RM with a progression of 5-15% for cardiovascular 
training and 30-50% for muscular strength.  
Modes of aerobic exercise included a variety of activities including the following: 
treadmill walking and running, walking outside, stationary bikes, recumbent stepper, 
AquaCiser, and arm ergometer. Modes of resistance training included the following: 
weight machines, free weights, bands, and body weight exercises. Flexibility training 
included static stretching, wall mounted range of motion wheel, and wall mounted 
stretching ropes. Detailed records of heart rate, blood pressure, and oxygen saturation 
responses for each participant were documented by the Cancer Exercise Specialist for 
each exercise session. Safety of the participants during the exercise intervention was a 
priority. All exercise was supervised and vitals were continuously monitored by Cancer 
Exercise Specialists and UNCCRI staff. SAS version 9.4 (Cary, NC) was used for all 
analyses. 
Results  
Data are presented as means ± SD. While both limbs were tested, dominant limbs 
were used for all analyses. Initial characteristics of participants are presented in Table 6. 
Treatment history and treatment status at time of testing is presented in Table 7. Cancer 














Age in years (mean ± SD)  62 ± 14 
Mass in kg (mean ± SD) 68 ± 12 
Height in cm (mean ± SD) 163 ± 18 
Female (n) 13 
Male (n) 8 






Surgery (%) 67 
Chemotherapy (%) 67 
Radiation (%) 42 
Treatment Status  
In-treatment (n) 2 



























Carcinoma  1 
Leukemia  1 




A series of repeated measures analysis of variance (RMANOVA) were utilized to 
evalute athe effects of exercise on total CRF (PFST), PFS subscales, HFI, QFI, peak hand 
force (PHF), and peak quadriceps force (PQF). Significant main effects were observed 
for PFST and all four subscales (p < .05). No significant main effects were found for 
either muscular fatigue measures or peak force. Additionally, there was no significant 
difference between genders for any of the dependent variables (p > .05). Where a main 
effect was observed, planned contrasts were used to compare pairs of time points to 













Means ± SD for each dependent measure by testing session 
 Pre 12 weeks 24 weeks 
PFST†‡ 4.1 ± 2.4 2.7 ± 2.0 2.2 ± 1.4 
PFSB† 3.7 ± 2.5 2.3 ± 2.3 1.6 ± 1.6 
PFSA†‡ 4.2 ± 2.8 2.6 ± 2.4 2.1 ± 1.8 
PFSS†‡ 4.4 ± 2.3 2.9 ± 2.1 2.4 ± 1.4 
PFSC† 4.1 ± 2.5 3.0 ± 1.9 2.5 ± 1.5 
HFI (%) 30.4 ± 17.1 29.2 ± 10.3 29.1 ± 13.0  
QFI (%) 34.3 ± 9.6 30.9 ± 12.9 29.2 ± 10.0 
PHF (kg) 17.7 ± 5.6 17.7 ± 5.6 18.9 ± 6.6 
PQF (N.m) 139.5 ± 50.4  151.3 ± 50.4 143.3 ± 44.9 
† p-value < .05 pre to 12 weeks 
‡ p-value < .05 pre to 24 weeks 
 
 P values for all contrasts are presented in Table 11. Results show significant 
decreases in PFST (p = .001), PFSB (p = .015), PFSA (p = .001), PFSS (p = .001), and 
PFSC (p = .004) following 12 weeks of the exercise intervention. Following 12 weeks of 
training there were no statistically significant changes in either measures of objective 
fatigue HFI (p = .606) and QFI (p = .455), or peak force PHF (p = .621) and PQF (p = 
.091). Testing following 24 weeks of the intervention resulted in significant decreases in 
PFST (p = .031), PFSA (p = .023), and PFSS (p = .016). While there were further 
decreases in both HFI and QFI following 12 and 24 weeks of training these changes were 











Contrast PFST PFSB PFSA PFSS PFSC 
Pre vs 12 weeks 
12 vs 24 weeks 

















Figure 3 represents changes in PFS scores from baseline pre-intervention to 12 
weeks and 24 weeks of exercise. Figure 4 summarizes changes in HFI and QFI scores 
following training.   
 
Figure 3. Changes in total Piper Fatigue Scale scores and PFS subscale scores following 
12 and 24 weeks of exercise. PFST = revised Piper Fatigue Scale total score. PFSB = 
behavioral subscale, PFSA = affective subscale, PFSS = sensory subscale, and PFSC = 




































Figure 4. Changes in muscular fatigue following 12 and 24 weeks of exercise. HFI 
represents the hand fatigue index and QFI represents the quadriceps fatigue index 
Discussion 
Investigations into physical activity in cancer survivors suggest that the majority 
of side effects from cancer and treatments appear to be ameliorated by exercise. Several 
review studies in addition to those done in our lab show strong evidence that exercise is 
an effective tool for rehabilitation after cancer (Burnham & Wilcox, 2002; Courneya, 
2003; Fong et al., 2012; Schneider et al., 2007a, 2007b; Speck et al., 2010; Sprod, Hsieh, 
Hayward, & Schneider, 2010; Stevinson et al., 2004). Studies measuring objective fatigue 
are minimal compared to the amount of literature using surveys to assess CRF. 
Considering that many factors can contribute to muscle fatigue, the lack of an objective 
measurement of CRF further hinders our understanding (Yavuzsen et al., 2009). In 
addition to the underlying factors associated with CRF, decreased physical activity as 
often seen in cancer patients can also be a contributing factor to increased fatigability 































can be considered as a therapeutic intervention for cancer survivors (Wolin et al., 2012). 
Specifically, exercise has the capacity to positively modify skeletal muscle and 
potentially reverse dysfunction. The repeated muscular contractions that take place 
during both aerobic and resistance exercise stimulate physiological adaptations such as 
increased protein synthesis, muscular hypertrophy, changes in contractile and 
mitochondrial function, metabolic changes, and modifications to signaling pathways 
(Christensen et al., 2014). Therefore, physical activity could be of particular importance 
to advanced stage and cachectic patients due to the potential to offset or increase muscle 
mass and strength (Stene et al., 2013). 
Results from this study showed significant decreases in subjective fatigue scores 
of total CRF in addition to all four subscales following 12 weeks of combined aerobic 
and resistance exercise. These results are similar to other exercise intervention studies 
that showed significant decreases in subjective scores of CRF in cancer patients 
(Adamsen et al., 2009; Arnold & Taylor, 2011; J. C. Brown et al., 2011; J. C. Brown, 
Huedo-Medina, et al., 2012; Dimeo, 2001; Haas, 2011; Keogh & MacLeod, 2012; 
Kuchinski et al., 2009; Litterini & Jette, 2011; Puetz & Herring, 2012; M. E. Schmidt et 
al., 2012; Schneider et al., 2007a, 2007b; van Waart et al., 2015; Velthuis et al., 2010; 
Wyrick & Davis, 2009). While there were further decreases in PFS scores from 12 to 24 
weeks, PFSB and PFSC were not found to be significant after 24 weeks of training. 
These results indicate while continued exercise is beneficial in reducing fatigue, the 
greatest changes were observed at the 12 week measurement point.  
The present study is in contrast to a study by Frontera, Meredith, O'Reilly, 






of the quadriceps following a 12 week resistance exercise session in older men. 
Differences between the present study from that of Frontera et al. (1988) is the addition 
of an aerobic component which may have offset some of the gains in muscle mass that 
may have resulted in a resistance only program. Also in contrast to the present study, J. S. 
Lee, Kim, Seo, Kim, and Yoon (2015) found significant increases in isokinetic 
quadriceps strength following an eight week combined aerobic and resistance training 
intervention in older women. An important distinction between the present study and the 
aforementioned studies is that they were not conducted in the cancer population. Several 
other studies conducted in the cancer population mention testing isokinetic knee strength 
prior to an exercise intervention, however, isokinetic strength outcomes were not 
mentioned in the results (Daley et al., 2007; M. E. Schmidt et al., 2015; M. E. Schmidt et 
al., 2013). It is difficult to discern if the outcomes were left out of results due to non-
significance or for another purpose. 
Results from the present study are also in contrast to other studies which have 
seen improvements in maximal strength following exercise training in cancer survivors 
(Adamsen et al., 2009; Courneya et al., 2007; Fong et al., 2012; Jarden et al., 2009; A. L. 
Schwartz & Winters-Stone, 2009; Segal et al., 2003; R. L. Siegel et al., 2014; Speck et 
al., 2010; van Waart et al., 2015; van Weert et al., 2006). Differences in outcome 
measures of strength could account for the non-significant change seen in the present 
study. Our study used torque (N.m) as outcome measures of strength where the 
aforementioned studies used increases in 1RM as an outcome of strength. 
The present study did not observe significant increases in handgrip strength 






to that of Monga et al. (1997) who did not observe increases in handgrip strength in 
cancer survivors following an exercise intervention. Present study results are however in 
contrast to a number of studies which have observed increased handgrip strength 
following an exercise intervention in cancer survivors (Oldervoll et al., 2011; K. M. 
Winters-Stone et al., 2012). Theoretically maximal force measurements should not have 
been different for our study; however, it is possible that participants did not give maximal 
effort, despite verbal encouragement, on the initial repetitions knowing the task involved 
completing 15 repetitions rather than one.  
Physical activity has been shown to decrease muscle fatigue in both healthy and 
diseased populations. The degree of decreases in fatigue depends largely on the prior 
training status of the individual as well as they type of exercise performed. A majority of 
the evidence citing reductions in muscle fatigue have been in the healthy population 
following a high intensity training program (Bogdanis, 2012). Intensity of exercise in this 
intervention was low to moderate and may not have been a large enough stimulus to 
result in significant decreases. Despite the lack of significance, reductions in muscular 
fatigue are important to improve survivor’s ability to carry out daily activities. 
Additionally, muscle fatigue may result in a higher risk of falls in this population and has 
been shown to be linked to premature death. Reductions in muscular fatigue may prolong 
survivorship for individuals experiencing fatigue (Bogdanis, 2012).  
Limitations to the present study include the absence of a control group. 
Reductions in subjective fatigue would likely be seen in absence of an exercise 
intervention due to time elapsed from treatment. Without a control group we cannot 






following usual care. While this cannot be stated for the present study, there is a 
substantial amount of literature that indicates exercise improves CRF when compared to a 
control group (Courneya, Friedenreich, et al., 2003; Courneya, Mackey, et al., 2003; 
Mock et al., 1997; Segal et al., 2003). This same limitation exists for the reductions seen 
in the present study regarding muscle fatigue outcomes. While decreases were seen in 
muscle fatigue, they were not found to be statistically significant, and without the 
presence of a control group we cannot accurately discern if there would not have been 
reductions in muscular fatigue following a usual care program. While the lack of a 
control group is generally seen as a limitation, exercise is a recommended practice for 
cancer survivors (Schmitz et al., 2010). Our clinic is in agreement with other researchers 
in that it seems unethical to withhold exercise from participants (K. M. Winters-Stone et 
al., 2012).  
A detailed characterization of CRF in addition to a more complete understanding 
of its etiology is necessary to develop targeted treatment mechanisms. It has been 
suggested that a more complete fatigue assessment would include both a subjective and 
physiological assessment (Portenoy & Itri, 1999). Considering the wide variety of 
questionnaires currently used to assess CRF it is difficult to compare outcomes. With 
more than 22 CRF scales in use, it is hard to clinically define the severity when 
investigations and interventions use different scales. Furthermore, considering the 
subjective nature of the fatigue dimension, a large amount of variability is possible in this 
type of outcome measurement. It is difficult to discern the effect of interventions to 
reduce CRF with the lack of a standard assessment tool. A more objective assessment of 






investigations should continue to evaluate the objective measures of fatigue in this 
population as well as the best mode and intensity of exercise to reduce muscular fatigue 
in cancer survivors.  
Subjective fatigue is a complex construct but has a connection to physiological 
capacity. The relationship between these dimensions currently remains unclear. It is 
difficult to discern whether the reductions in subjective fatigue are due to the reductions 
in muscular fatigue, or if the opposite is true. Despite the well-known effects of cancer 
and its treatments on skeletal muscle mass, the effects of cancer and its effects on 
muscular fatigue is less clear. To our knowledge, this is the first study to evaluate 
objectively measured muscular fatigue in cancer patients following an exercise 
intervention. Results from this study show that cancer rehabilitation is effective in 
reducing both psychological outcomes of fatigue and should be included in interventions 
aimed at reducing CRF.  
In summary, CRF is understood to be largely a subjective symptom resulting from 
cancer and its treatment. Investigations into the etiology and mechanisms of CRF; 
however, suggest physiological and biological mechanisms to be the underlying cause. 
Therefore it is important to investigate interventions of a physiological nature such as 
exercise as a form of treatment. Results from this investigation show that a supervised 
combined aerobic and resistance cancer rehabilitation program is effective for reducing 
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 Results from this study show that objective measures of upper body levels of 
fatigue, as measured though a hand dynamometer, are significantly related to subjective 
feelings of cancer-related fatigue (CRF). Additionally, handgrip strength was shown to be 
associated with lower levels of CRF. This objective fatigue measure is quick, 
inexpensive, and easily administered by clinical staff. Incorporating a measure of 
muscular fatigue in addition to subjective measures may give clinicians a better 
understanding of fatigue and how it affects an individual’s ability to participate in 
specific rehabilitation exercises. In contrast, lower body fatigue was not related to 
subjective feelings of fatigue indicating that muscles of the lower body may be less 
affected by CRF.  
 A supervised aerobic and resistance exercise program was shown to be effective 
in reducing subjective CRF in as few as 12 weeks. Continued physical activity further 
reduced subjective feelings of fatigue following 24 weeks of exercise indicating cancer 
rehabilitation is an effective tool for reducing CRF. Currently the optimal mode and 
intensity of exercise to reduce muscular fatigue in the cancer population is unclear. The 
effect of exercise on muscular fatigue in cancer survivors remains unclear and should 
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